[
  {
    "id": 123461,
    "drug": {
      "current_status": "MARKETED",
      "id": 66914,
      "drug_code": 97348,
      "updated_date": "2025-12-03T00:34:08-05:00",
      "company": {
        "id": 1322,
        "created_date": "2017-03-09T13:24:10-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 16867,
        "mfr_code": "",
        "name": "INDIVIOR UK LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "THE CHAPLEO BUILDING, HENRY BOOT WAY",
        "province": "--",
        "country": "UNITED KINGDOM",
        "city": "HULL",
        "postal_code": "HU4 7DY",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263733,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02483084",
      "brand_name": "SUBLOCADE",
      "brand_name_fr": "",
      "descriptor": "PREFILLED SYRINGE & POUCH  - SINGLE DOSE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241016"
    },
    "created_date": "2020-09-01T13:05:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02483084",
    "company_name": "INDIVIOR UK LIMITED",
    "atc_number": "N07BC",
    "anticipated_start_date": "2020-09-01T00:00:00-04:00",
    "estimated_end_date": "2021-03-09T00:00:00-05:00",
    "actual_start_date": "2020-09-01T00:00:00-04:00",
    "actual_end_date": "2021-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-10T13:12:49-05:00",
    "status": "resolved",
    "en_comments": "https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods/information-provisions-related-drugs-biocides/tier-3-shortages.html",
    "fr_comments": "https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/conformite-application-loi/covid19-arrete-urgence-drogues-instruments-medicaux-aliments-speciales/renseignements-dispositions-relatives-drogues-biocides/penuries-niveau-3.html",
    "en_drug_brand_name": "SUBLOCADE",
    "en_drug_common_name": "Buprenorphine extended release injection",
    "fr_drug_brand_name": "Sublocade",
    "fr_drug_common_name": "Buprénorphine a liberation prolongée pour injection",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Solution (à libération prolongée)",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1 syringe/pouch",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123466,
    "drug": {
      "current_status": "MARKETED",
      "id": 66916,
      "drug_code": 97349,
      "updated_date": "2025-12-03T00:34:08-05:00",
      "company": {
        "id": 1322,
        "created_date": "2017-03-09T13:24:10-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 16867,
        "mfr_code": "",
        "name": "INDIVIOR UK LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "THE CHAPLEO BUILDING, HENRY BOOT WAY",
        "province": "--",
        "country": "UNITED KINGDOM",
        "city": "HULL",
        "postal_code": "HU4 7DY",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263734,
          "ingredient": {
            "id": 3394,
            "ingredient_code": 12033,
            "en_name": "BUPRENORPHINE",
            "fr_name": "Buprénorphine (Chlorhydrate de buprénorphine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02483092",
      "brand_name": "SUBLOCADE",
      "brand_name_fr": "",
      "descriptor": "PREFILLED SYRINGE & POUCH  - SINGLE DOSE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142241016"
    },
    "created_date": "2020-09-01T13:13:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02483092",
    "company_name": "INDIVIOR UK LIMITED",
    "atc_number": "N07BC",
    "anticipated_start_date": "2020-09-01T00:00:00-04:00",
    "estimated_end_date": "2021-01-31T00:00:00-05:00",
    "actual_start_date": "2020-09-01T00:00:00-04:00",
    "actual_end_date": "2021-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-27T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SUBLOCADE",
    "en_drug_common_name": "Buprenorphine extended release injection",
    "fr_drug_brand_name": "Sublocade",
    "fr_drug_common_name": "Buprénorphine a liberation prolongée pour injection",
    "en_ingredients": "BUPRENORPHINE",
    "fr_ingredients": "Buprénorphine",
    "drug_strength": "300MG",
    "drug_dosage_form": "SOLUTION (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Solution (à libération prolongée)",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1 syringe/pouch",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123492,
    "drug": {
      "current_status": "MARKETED",
      "id": 57817,
      "drug_code": 96052,
      "updated_date": "2025-12-03T00:33:38-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262972,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471426",
      "brand_name": "M-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2020-09-01T15:34:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02471426",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2021-05-13T00:00:00-04:00",
    "actual_start_date": "2020-06-12T00:00:00-04:00",
    "actual_end_date": "2021-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-05-07T19:47:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "M-ESCITALOPRAM",
    "en_drug_common_name": "M-Escitalopram ( 20 mg )",
    "fr_drug_brand_name": "Escitalopram",
    "fr_drug_common_name": "Escitalopram",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123494,
    "drug": {
      "current_status": "MARKETED",
      "id": 10520,
      "drug_code": 65841,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253985,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242163",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545001"
    },
    "created_date": "2020-09-01T15:38:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242163",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2020-09-16T00:00:00-04:00",
    "estimated_end_date": "2020-10-29T00:00:00-04:00",
    "actual_start_date": "2020-09-17T00:00:00-04:00",
    "actual_end_date": "2020-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-29T14:30:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "MORPHINE SULFATE",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "MORPHINE SULFATE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123497,
    "drug": {
      "current_status": "DORMANT",
      "id": 66484,
      "drug_code": 97988,
      "updated_date": "2025-12-03T02:32:47-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369654,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02489805",
      "brand_name": "M-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666002"
    },
    "created_date": "2020-09-01T15:40:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489805",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-12-28T00:00:00-05:00",
    "actual_start_date": "2020-08-24T00:00:00-04:00",
    "actual_end_date": "2020-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-12-12T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-LANSOPRAZOLE",
    "en_drug_common_name": "M-Lansoprazole (15 mg)",
    "fr_drug_brand_name": "Lansoprazole",
    "fr_drug_common_name": "Lansoprazole",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123499,
    "drug": {
      "current_status": "MARKETED",
      "id": 3942,
      "drug_code": 19594,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252515,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172119",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 125MCG",
      "pediatric_flag": false,
      "accession_number": "81891",
      "number_of_ais": "1",
      "ai_group_no": "0107794021"
    },
    "created_date": "2020-09-01T15:43:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172119",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-09-15T00:00:00-04:00",
    "estimated_end_date": "2020-10-13T00:00:00-04:00",
    "actual_start_date": "2020-09-21T00:00:00-04:00",
    "actual_end_date": "2020-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-14T11:50:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "125MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123502,
    "drug": {
      "current_status": "MARKETED",
      "id": 63408,
      "drug_code": 96730,
      "updated_date": "2025-12-03T00:33:49-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263287,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476290",
      "brand_name": "M-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2020-09-01T15:45:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02476290",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2020-12-07T00:00:00-05:00",
    "actual_start_date": "2020-07-09T00:00:00-04:00",
    "actual_end_date": "2020-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-12-11T21:58:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "M-PRAVASTATIN",
    "en_drug_common_name": "M-Pravastatin (40 mg)",
    "fr_drug_brand_name": "Pravastatin",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123504,
    "drug": {
      "current_status": "MARKETED",
      "id": 3948,
      "drug_code": 19597,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252518,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172143",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 200MCG",
      "pediatric_flag": false,
      "accession_number": "81894",
      "number_of_ais": "1",
      "ai_group_no": "0107794022"
    },
    "created_date": "2020-09-01T15:46:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172143",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-10-21T00:00:00-04:00",
    "estimated_end_date": "2020-12-01T00:00:00-05:00",
    "actual_start_date": "2020-10-22T00:00:00-04:00",
    "actual_end_date": "2020-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-01T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "200MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123507,
    "drug": {
      "current_status": "MARKETED",
      "id": 57196,
      "drug_code": 95569,
      "updated_date": "2025-12-03T00:33:30-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262677,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467305",
      "brand_name": "M-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2020-09-01T15:49:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467305",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-09-21T00:00:00-04:00",
    "actual_start_date": "2020-07-13T00:00:00-04:00",
    "actual_end_date": "2020-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-17T14:27:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "M-PREGABALIN",
    "en_drug_common_name": "M-Pregabalin (50 mg)",
    "fr_drug_brand_name": "Pregabalin",
    "fr_drug_common_name": "Pregabalin",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123511,
    "drug": {
      "current_status": "MARKETED",
      "id": 55363,
      "drug_code": 94425,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262096,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457172",
      "brand_name": "MYLAN-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258001"
    },
    "created_date": "2020-09-01T17:06:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457172",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2020-11-06T00:00:00-05:00",
    "actual_end_date": "2020-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-14T11:56:35-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "MYLAN-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123514,
    "drug": {
      "current_status": "MARKETED",
      "id": 14100,
      "drug_code": 74133,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255091,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256096",
      "brand_name": "MYLAN-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2020-09-01T17:07:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256096",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-09-08T00:00:00-04:00",
    "actual_start_date": "2020-08-29T00:00:00-04:00",
    "actual_end_date": "2020-09-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-10T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123542,
    "drug": {
      "current_status": "MARKETED",
      "id": 4572,
      "drug_code": 228,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250134,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037834",
      "brand_name": "SODIUM CHLORIDE IRRIGATION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "08228",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2020-09-01T19:56:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037834",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2020-09-03T00:00:00-04:00",
    "estimated_end_date": "2020-09-14T00:00:00-04:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2020-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "This issue has been resolved.",
    "en_drug_brand_name": "SODIUM CHLORIDE IRRIGATION USP",
    "en_drug_common_name": "Sodium Chloride Irrigation USP",
    "fr_drug_brand_name": "Chlorure de sodium à irrigation USP",
    "fr_drug_common_name": "Chlorure de sodium à irrigation USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAPERITONEAL\r\nIRRIGATION\r\nTOPICAL\r\nINTRAPERITONEAL\r\nIRRIGATION\r\nTOPICAL",
    "drug_route_fr": "Intrapéritonéale\r\nIrrigation\r\nTopique\r\nIntrapéritonéale\r\nIrrigation\r\nTopique",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123558,
    "drug": {
      "current_status": "DORMANT",
      "id": 24564,
      "drug_code": 87165,
      "updated_date": "2025-05-15T06:55:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368788,
          "ingredient": {
            "id": 3156,
            "ingredient_code": 13346,
            "en_name": "ELETRIPTAN",
            "fr_name": "Élétriptan (Bromhydrate d'élétriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386062",
      "brand_name": "APO-ELETRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150241002"
    },
    "created_date": "2020-09-02T12:41:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386062",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "hc_updated_date": "2021-11-19T16:48:08-05:00",
    "estimated_end_date": "2021-11-19T00:00:00-05:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2021-11-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-11-19T16:48:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ELETRIPTAN",
    "en_drug_common_name": "ELETRIPTAN",
    "fr_drug_brand_name": "APO-ELETRIPTAN",
    "fr_drug_common_name": "ELETRIPTAN",
    "en_ingredients": "ELETRIPTAN",
    "fr_ingredients": "ELETRIPTAN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123561,
    "drug": {
      "current_status": "MARKETED",
      "id": 11788,
      "drug_code": 69269,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254376,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02245247",
      "brand_name": "APO-GLICLAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934001"
    },
    "created_date": "2020-09-02T12:45:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245247",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-09-15T00:00:00-04:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2020-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-14T13:20:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GLICLAZIDE",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "APO-GLICLAZIDE",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123566,
    "drug": {
      "current_status": "MARKETED",
      "id": 20002,
      "drug_code": 81335,
      "updated_date": "2025-05-15T02:32:26-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257040,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02327856",
      "brand_name": "APO-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101048004"
    },
    "created_date": "2020-09-02T12:54:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327856",
    "company_name": "APOTEX INC",
    "atc_number": "C03AA",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "estimated_end_date": "2020-09-09T00:00:00-04:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2020-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-09T13:07:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDRO",
    "en_drug_common_name": "HYDRO",
    "fr_drug_brand_name": "APO-HYDRO",
    "fr_drug_common_name": "HYDRO",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123571,
    "drug": {
      "current_status": "MARKETED",
      "id": 58732,
      "drug_code": 95849,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262846,
          "ingredient": {
            "id": 1122,
            "ingredient_code": 2097,
            "en_name": "PINAVERIUM BROMIDE",
            "fr_name": "Bromure de pinavérium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02469685",
      "brand_name": "PINAVERIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113429002"
    },
    "created_date": "2020-09-02T12:58:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469685",
    "company_name": "APOTEX INC",
    "atc_number": "A03AX",
    "atc_description": "DRUGS FOR FUNCTIONAL BOWEL DISORDERS",
    "estimated_end_date": "2020-10-01T00:00:00-04:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T12:58:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PINAVERIUM",
    "en_drug_common_name": "PINAVERIUM",
    "fr_drug_brand_name": "APO-PINAVERIUM",
    "fr_drug_common_name": "PINAVERIUM",
    "en_ingredients": "PINAVERIUM BROMIDE",
    "fr_ingredients": "Bromure de pinavérium",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123574,
    "drug": {
      "current_status": "MARKETED",
      "id": 310,
      "drug_code": 10829,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251401,
          "ingredient": {
            "id": 236,
            "ingredient_code": 11108,
            "en_name": "PRAZOSIN",
            "fr_name": "Prazosine (Chlorhydrate de prazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00882828",
      "brand_name": "APO-PRAZO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70922",
      "number_of_ais": "1",
      "ai_group_no": "0111527002"
    },
    "created_date": "2020-09-02T13:02:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00882828",
    "company_name": "APOTEX INC",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2020-10-14T00:00:00-04:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2020-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-16T16:09:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAZO TAB 2MG",
    "en_drug_common_name": "PRAZO",
    "fr_drug_brand_name": "APO-PRAZO",
    "fr_drug_common_name": "PRAZO",
    "en_ingredients": "PRAZOSIN",
    "fr_ingredients": "PRAZO",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123581,
    "drug": {
      "current_status": "MARKETED",
      "id": 22344,
      "drug_code": 84741,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257998,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362406",
      "brand_name": "APO-TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED-RELEASE TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2020-09-02T13:11:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362406",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2021-02-26T00:00:00-05:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2021-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-23T13:51:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN",
    "fr_drug_brand_name": "APO-TAMSULOSIN",
    "fr_drug_common_name": "TAMSULOSIN",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123586,
    "drug": {
      "current_status": "MARKETED",
      "id": 56740,
      "drug_code": 90451,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260267,
          "ingredient": {
            "id": 3368,
            "ingredient_code": 20097,
            "en_name": "VARENICLINE",
            "fr_name": "Varénicline (Tartrate de varénicline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02419890",
      "brand_name": "APO-VARENICLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152190002"
    },
    "created_date": "2020-09-02T13:20:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02419890",
    "company_name": "APOTEX INC",
    "atc_number": "N07BA",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2020-09-29T00:00:00-04:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2020-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-14T13:41:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VARENICLINE",
    "en_drug_common_name": "VARENICLINE",
    "fr_drug_brand_name": "APO-VARENICLINE",
    "fr_drug_common_name": "VARINICLINE",
    "en_ingredients": "VARENICLINE",
    "fr_ingredients": "VARENICLINE",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "56 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123589,
    "drug": {
      "current_status": "MARKETED",
      "id": 57148,
      "drug_code": 92001,
      "updated_date": "2025-05-15T02:34:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260877,
          "ingredient": {
            "id": 3368,
            "ingredient_code": 20097,
            "en_name": "VARENICLINE",
            "fr_name": "Varénicline (Tartrate de varénicline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260876,
          "ingredient": {
            "id": 3368,
            "ingredient_code": 20097,
            "en_name": "VARENICLINE",
            "fr_name": "Varénicline (Tartrate de varénicline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02435675",
      "brand_name": "APO-VARENICLINE",
      "brand_name_fr": "",
      "descriptor": "STARTER PACK (COMBOPACK)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252269001"
    },
    "created_date": "2020-09-02T13:36:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435675",
    "company_name": "APOTEX INC",
    "atc_number": "N07BA",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2020-09-29T00:00:00-04:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2020-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-14T13:43:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VARENICLINE",
    "en_drug_common_name": "VARENICLINE",
    "fr_drug_brand_name": "APO-VARENICLINE",
    "fr_drug_common_name": "VARENICLINE",
    "en_ingredients": "VARENICLINE\r\nVARENICLINE",
    "fr_ingredients": "VARENICLINE",
    "drug_strength": "0.5MG\r\n1MG",
    "drug_dosage_form": "KIT\r\nTABLET",
    "drug_dosage_form_fr": "Trousse\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "53 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123592,
    "drug": {
      "current_status": "MARKETED",
      "id": 66135,
      "drug_code": 97571,
      "updated_date": "2025-05-15T02:37:29-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263887,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "50",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02485478",
      "brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830009"
    },
    "created_date": "2020-09-02T13:51:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485478",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2020-09-02T00:00:00-04:00",
    "estimated_end_date": "2020-09-16T00:00:00-04:00",
    "actual_start_date": "2020-09-02T00:00:00-04:00",
    "actual_end_date": "2020-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-17T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "en_drug_common_name": "CLINDAMYCIN INJECTION IN 5% DEXTROSE",
    "fr_drug_brand_name": "Clindamycine injection dans 5% dextrose",
    "fr_drug_common_name": "Clindamycine injection dans 5% dextrose",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "clindamycine",
    "drug_strength": "600MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "600mg/50mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123599,
    "drug": {
      "current_status": "DORMANT",
      "id": 58690,
      "drug_code": 94341,
      "updated_date": "2025-05-15T06:55:57-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8369407,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02456524",
      "brand_name": "ACYCLOVIR SODIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506007"
    },
    "created_date": "2020-09-02T15:15:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456524",
    "company_name": "STERIMAX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2020-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-09T15:19:40-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACYCLOVIR SODIUM INJECTION",
    "en_drug_common_name": "ACYCLOVIR SODIUM INJECTION",
    "fr_drug_brand_name": "ACYCLOVIR SODIQUE INJECTABLE",
    "fr_drug_common_name": "ACYCLOVIR SODIQUE INJECTABLE",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS 10 ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123610,
    "drug": {
      "current_status": "MARKETED",
      "id": 32008,
      "drug_code": 9509,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251174,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00786543",
      "brand_name": "DILAUDID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68694",
      "number_of_ais": "1",
      "ai_group_no": "0108698005"
    },
    "created_date": "2020-09-02T19:46:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786543",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2020-09-01T00:00:00-04:00",
    "estimated_end_date": "2020-09-08T00:00:00-04:00",
    "actual_start_date": "2020-09-01T00:00:00-04:00",
    "actual_end_date": "2020-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-09-05T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DILAUDID",
    "en_drug_common_name": "Dilaudid",
    "fr_drug_brand_name": "Dilaudid",
    "fr_drug_common_name": "Dilaudid",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123648,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28330,
      "drug_code": 90476,
      "updated_date": "2025-05-15T04:22:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354335,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420155",
      "brand_name": "ACT CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2020-09-03T16:23:27-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02420155",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_discontinuation_date": "2021-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "TO BE DISC",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-03T16:23:41-04:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "ACT CELECOXIB",
    "en_drug_common_name": "CELECOXIB 100MG CAPS",
    "fr_drug_brand_name": "ACT-CELECOXIB 100MG CAPS",
    "fr_drug_common_name": "CELECOXIB 100MG CAPS",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123651,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28332,
      "drug_code": 90477,
      "updated_date": "2025-05-15T04:22:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354336,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420163",
      "brand_name": "ACT CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043002"
    },
    "created_date": "2020-09-03T16:25:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02420163",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_discontinuation_date": "2021-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "TO BE DISC",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-03T16:25:34-04:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "ACT CELECOXIB",
    "en_drug_common_name": "CELECOXIB 200MG CAP",
    "fr_drug_brand_name": "ACT-CELECOXIB 200MG CAP",
    "fr_drug_common_name": "CELECOXIB 200MG CAP",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's & 500's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123720,
    "drug": {
      "current_status": "MARKETED",
      "id": 8552,
      "drug_code": 60109,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253450,
          "ingredient": {
            "id": 526,
            "ingredient_code": 10128,
            "en_name": "AZATHIOPRINE",
            "fr_name": "Azathioprine (Azathioprine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236819",
      "brand_name": "TEVA-AZATHIOPRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101830001"
    },
    "created_date": "2020-09-03T18:29:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236819",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2020-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-03T20:09:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AZATHIOPRINE",
    "en_drug_common_name": "AZATHIOPRINE 50MG TAB",
    "fr_drug_brand_name": "TEVA-AZATHIOPRINE 50MG TAB",
    "fr_drug_common_name": "AZATHIOPRINE 50MG TAB",
    "en_ingredients": "AZATHIOPRINE",
    "fr_ingredients": "Azathioprine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123723,
    "drug": {
      "current_status": "MARKETED",
      "id": 15840,
      "drug_code": 76588,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255672,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280205",
      "brand_name": "TEVA-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555004"
    },
    "created_date": "2020-09-03T18:30:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02280205",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2020-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-15T17:26:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BETAHISTINE",
    "en_drug_common_name": "BETAHISTINE 24MG TAB",
    "fr_drug_brand_name": "TEVA-BETAHISTINE 24MG TAB",
    "fr_drug_common_name": "BETAHISTINE 24MG TAB",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "24MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "UD 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123726,
    "drug": {
      "current_status": "MARKETED",
      "id": 21538,
      "drug_code": 83931,
      "updated_date": "2025-05-15T02:32:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257694,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354101",
      "brand_name": "TEVA-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2020-09-03T18:31:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354101",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-03-31T00:00:00-04:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2021-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-07T18:19:55-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EZETIMIBE",
    "en_drug_common_name": "EZETIMIBE 10MG TAB",
    "fr_drug_brand_name": "TEVA-EZETIMIBE 10MG TAB",
    "fr_drug_common_name": "EZETIMIBE 10MG TAB",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123729,
    "drug": {
      "current_status": "MARKETED",
      "id": 11566,
      "drug_code": 68490,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254312,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244513",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "100MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2020-09-03T18:32:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244513",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-01T17:52:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN 100MG CAP",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 100MG CAP",
    "fr_drug_common_name": "GABAPENTIN 100MG CAP",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123732,
    "drug": {
      "current_status": "MARKETED",
      "id": 7722,
      "drug_code": 5073,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250705,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00342106",
      "brand_name": "TEVA-CEPHALEXIN 125",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59604",
      "number_of_ais": "1",
      "ai_group_no": "0105911001"
    },
    "created_date": "2020-09-03T18:33:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00342106",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN 125",
    "en_drug_common_name": "CEPHALEXIN SUSP 125MG/5ML",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN SUSP 125MG/5ML",
    "fr_drug_common_name": "CEPHALEXIN SUSP 125MG/5ML",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "125MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 & 150ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123735,
    "drug": {
      "current_status": "MARKETED",
      "id": 3620,
      "drug_code": 19058,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252415,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02173360",
      "brand_name": "TEVA-SALBUTAMOL STERINEBS P.F.",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81347",
      "number_of_ais": "1",
      "ai_group_no": "0108887001"
    },
    "created_date": "2020-09-03T18:35:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02173360",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2020-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-17T20:52:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SALBUTAMOL STERINEBS P.F.",
    "en_drug_common_name": "SALBUTAMOL 2MG/ML NEBS",
    "fr_drug_brand_name": "TEVA-SALBUTAMOL 2MG/ML NEBS",
    "fr_drug_common_name": "SALBUTAMOL 2MG/ML NEBS",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20 x 2.5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123738,
    "drug": {
      "current_status": "MARKETED",
      "id": 11704,
      "drug_code": 6892,
      "updated_date": "2025-05-15T02:30:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250972,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250971,
          "ingredient": {
            "id": 1010,
            "ingredient_code": 7408,
            "en_name": "SPIRONOLACTONE",
            "fr_name": "Spironolactone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00657182",
      "brand_name": "TEVA-SPIRONOLACTONE/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64297",
      "number_of_ais": "2",
      "ai_group_no": "0201064002"
    },
    "created_date": "2020-09-03T18:35:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00657182",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03EA",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "estimated_end_date": "2021-01-31T00:00:00-05:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2021-02-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-05T16:02:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SPIRONOLACTONE/HCTZ",
    "en_drug_common_name": "SPIRONOLACTONE HCTZ 50/50MG TAB",
    "fr_drug_brand_name": "TEVA-SPIRONOLACTONE HCTZ 50/50MG TAB",
    "fr_drug_common_name": "SPIRONOLACTONE HCTZ 50/50MG TAB",
    "en_ingredients": "SPIRONOLACTONE\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Spironolactone\r\nHydrochlorothiazide",
    "drug_strength": "50MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123741,
    "drug": {
      "current_status": "MARKETED",
      "id": 15466,
      "drug_code": 76056,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255534,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02275058",
      "brand_name": "TEVA-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294005"
    },
    "created_date": "2020-09-03T18:37:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02275058",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2020-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-24T17:53:43-04:00",
    "status": "resolved",
    "en_comments": "Item is discontinued/transitioned to Act",
    "en_drug_brand_name": "TEVA-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR 150MG CAP",
    "fr_drug_brand_name": "TEVA-VENLAFAXINE XR 150MG CAP",
    "fr_drug_common_name": "VENLAFAXINE XR 150MG CAP",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123744,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28722,
      "drug_code": 90846,
      "updated_date": "2025-05-15T04:22:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8354578,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423766",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "5MG/ML; 15MG/3ML; 50MG/10ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2020-09-03T19:36:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423766",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Item has been discontinued.",
    "fr_comments": "L'item est discontinué.",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10 x 1ML VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123764,
    "drug": {
      "current_status": "MARKETED",
      "id": 3318,
      "drug_code": 18480,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252307,
          "ingredient": {
            "id": 1402,
            "ingredient_code": 215,
            "en_name": "DEXRAZOXANE",
            "fr_name": "Dexrazoxane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02153432",
      "brand_name": "ZINECARD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80739",
      "number_of_ais": "1",
      "ai_group_no": "0152586001"
    },
    "created_date": "2020-09-04T16:05:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02153432",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "V03AF",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "actual_start_date": "2020-09-04T00:00:00-04:00",
    "actual_end_date": "2021-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-17T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZINECARD",
    "en_drug_common_name": "ZINECARD",
    "fr_drug_brand_name": "ZINECARD",
    "fr_drug_common_name": "ZINECARD",
    "en_ingredients": "DEXRAZOXANE",
    "fr_ingredients": "Dexrazoxane",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25ML Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123857,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2094,
      "drug_code": 14413,
      "updated_date": "2025-05-15T03:40:37-04:00",
      "company": {
        "id": 318,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4174,
        "mfr_code": "FEI08",
        "name": "FERRING INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "500",
        "street_name": "200 YORKLAND BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2J 5C1",
        "post_office_box": "",
        "contact_information": "1-800-263-4057"
      },
      "drug_ingredients": [
        {
          "id": 8293448,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402516",
      "brand_name": "DDAVP RHINYLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76030",
      "number_of_ais": "1",
      "ai_group_no": "0112050005"
    },
    "created_date": "2020-09-08T19:39:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402516",
    "company_name": "FERRING INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "anticipated_start_date": "2021-01-15T00:00:00-05:00",
    "estimated_end_date": "2021-01-27T00:00:00-05:00",
    "actual_start_date": "2021-01-15T00:00:00-05:00",
    "actual_end_date": "2021-01-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-02T15:44:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DDAVP RHINYLE",
    "en_drug_common_name": "Desmopressin acetate nasal solution",
    "fr_drug_brand_name": "DDAVP Rhinyle",
    "fr_drug_common_name": "Solution nasale d’acétate de desmopressine",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "2.5 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123862,
    "drug": {
      "current_status": "MARKETED",
      "id": 10364,
      "drug_code": 65503,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253919,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        },
        {
          "id": 8253918,
          "ingredient": {
            "id": 1006,
            "ingredient_code": 7498,
            "en_name": "NORETHINDRONE ACETATE",
            "fr_name": "Acétate de noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02241837",
      "brand_name": "ESTALIS 250/50 MCG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242942006"
    },
    "created_date": "2020-09-08T20:35:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241837",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "G03FA",
    "atc_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
    "anticipated_start_date": "2020-09-04T00:00:00-04:00",
    "estimated_end_date": "2020-09-24T00:00:00-04:00",
    "actual_start_date": "2020-09-02T00:00:00-04:00",
    "actual_end_date": "2020-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-23T12:31:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTALIS 250/50 MCG",
    "en_drug_common_name": "ESTALIS 250/50 MCG 8'S",
    "fr_drug_brand_name": "ESTALIS 250/50 MCG",
    "fr_drug_common_name": "ESTALIS 250/50 MCG 8'S",
    "en_ingredients": "ESTRADIOL\r\nNORETHINDRONE ACETATE",
    "fr_ingredients": "Estradiol\r\nAcétate de noréthindrone",
    "drug_strength": "50MCG\r\n250MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123865,
    "drug": {
      "current_status": "MARKETED",
      "id": 10362,
      "drug_code": 65502,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253917,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        },
        {
          "id": 8253916,
          "ingredient": {
            "id": 1006,
            "ingredient_code": 7498,
            "en_name": "NORETHINDRONE ACETATE",
            "fr_name": "Acétate de noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "140",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02241835",
      "brand_name": "ESTALIS 140/50 MCG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242942005"
    },
    "created_date": "2020-09-08T20:39:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241835",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "G03FA",
    "atc_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
    "anticipated_start_date": "2020-09-04T00:00:00-04:00",
    "estimated_end_date": "2020-09-24T00:00:00-04:00",
    "actual_start_date": "2020-09-03T00:00:00-04:00",
    "actual_end_date": "2020-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTALIS 140/50 MCG",
    "en_drug_common_name": "ESTALIS 140/50 MCG 8'S",
    "fr_drug_brand_name": "ESTALIS 140/50MCG",
    "fr_drug_common_name": "ESTALIS 140/50MCG 8'S",
    "en_ingredients": "ESTRADIOL\r\nNORETHINDRONE ACETATE",
    "fr_ingredients": "Estradiol\r\nAcétate de noréthindrone",
    "drug_strength": "50MCG\r\n140MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123875,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9536,
      "drug_code": 6311,
      "updated_date": "2025-05-15T03:29:43-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8280180,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00658855",
      "brand_name": "LOPRESOR SR 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62779",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2020-09-08T21:03:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00658855",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-08-13T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Business decision to stop manufacturing,  will be discontinued",
    "fr_comments": "Decision commercial d'arreter la fabrication, sera discontinue.",
    "en_drug_brand_name": "LOPRESOR SR 100MG",
    "en_drug_common_name": "Lopresor SR 100MG",
    "fr_drug_brand_name": "LOPRESOR SR 100MG",
    "fr_drug_common_name": "LOPRESOR SR 100MG X 100'S",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123880,
    "drug": {
      "current_status": "MARKETED",
      "id": 884,
      "drug_code": 11969,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251588,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "01940414",
      "brand_name": "VOLTAREN OPHTHA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72938",
      "number_of_ais": "1",
      "ai_group_no": "0114417004"
    },
    "created_date": "2020-09-08T21:12:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01940414",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BC",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2020-09-04T00:00:00-04:00",
    "estimated_end_date": "2020-10-19T00:00:00-04:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VOLTAREN OPHTHA",
    "en_drug_common_name": "VOLTAREN 0.1% SOLN 5ML",
    "fr_drug_brand_name": "VOLTAREN",
    "fr_drug_common_name": "VOLTAREN 0.1% SOLN 5ML",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123884,
    "drug": {
      "current_status": "MARKETED",
      "id": 10054,
      "drug_code": 6461,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250895,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00632724",
      "brand_name": "VOLTAREN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63143",
      "number_of_ais": "1",
      "ai_group_no": "0114417002"
    },
    "created_date": "2020-09-08T21:15:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00632724",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2020-09-04T00:00:00-04:00",
    "estimated_end_date": "2020-10-16T00:00:00-04:00",
    "actual_start_date": "2020-09-02T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T21:09:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VOLTAREN",
    "en_drug_common_name": "VOLTAREN 50 MG SUPP (5X6)",
    "fr_drug_brand_name": "VOLTAREN",
    "fr_drug_common_name": "VOLTAREN 50MG SUPP (5 X6)",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "5 X 6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123888,
    "drug": {
      "current_status": "MARKETED",
      "id": 8334,
      "drug_code": 5707,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250813,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00614254",
      "brand_name": "TOBREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61339",
      "number_of_ais": "1",
      "ai_group_no": "0110230005"
    },
    "created_date": "2020-09-08T21:25:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00614254",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01AA",
    "atc_description": "ANTIINFECTIVES",
    "anticipated_start_date": "2020-09-14T00:00:00-04:00",
    "estimated_end_date": "2021-03-15T00:00:00-04:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2021-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-02-24T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TOBREX",
    "en_drug_common_name": "TOBREX OINTMENT 3.5 G",
    "fr_drug_brand_name": "TOBREX",
    "fr_drug_common_name": "TOBREX 3.5G",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "0.3%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "3.5 G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123892,
    "drug": {
      "current_status": "DORMANT",
      "id": 17102,
      "drug_code": 78142,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368080,
          "ingredient": {
            "id": 1586,
            "ingredient_code": 141,
            "en_name": "BICALUTAMIDE",
            "fr_name": "Bicalutamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02296063",
      "brand_name": "APO-BICALUTAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127996001"
    },
    "created_date": "2020-09-09T12:31:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02296063",
    "company_name": "APOTEX INC",
    "atc_number": "L02BB",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2020-10-01T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-28T15:06:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BICALUTAMIDE",
    "en_drug_common_name": "BICALUTAMIDE",
    "fr_drug_brand_name": "APO-BICALUTAMIDE",
    "fr_drug_common_name": "BICALUTAMIDE",
    "en_ingredients": "BICALUTAMIDE",
    "fr_ingredients": "Bicalutamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123894,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6288,
      "drug_code": 43137,
      "updated_date": "2025-05-15T03:49:45-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8312804,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02213745",
      "brand_name": "ZOFRAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9432",
      "number_of_ais": "1",
      "ai_group_no": "0131120004"
    },
    "created_date": "2020-09-09T12:35:34-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02213745",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "discontinuation_date": "2021-04-19T00:00:00-04:00",
    "anticipated_discontinuation_date": "2021-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-05-05T19:14:20-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ZOFRAN",
    "en_drug_common_name": "ZOFRAN INJ 4MG AMPS 2ML 5'S",
    "fr_drug_brand_name": "ZOFRAN",
    "fr_drug_common_name": "ZOFRAN INJ 4MG AMPS 2ML 5'S",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2ML X 5'S",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123897,
    "drug": {
      "id": 5034,
      "drug_code": 29542,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252779,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02106272",
      "brand_name": "TRANDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "F6256",
      "number_of_ais": "1",
      "ai_group_no": "0116170001"
    },
    "created_date": "2020-09-09T12:43:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02106272",
    "company_name": "PALADIN LABS INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2020-09-14T00:00:00-04:00",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-11T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-11-05T15:38:22-05:00",
    "status": "resolved",
    "en_comments": "Product on allocation - Full orders may not be shipped",
    "fr_comments": "Produit en allocation - Les commandes ne seront peut-être pas livré en entier.",
    "en_drug_brand_name": "TRANDATE",
    "en_drug_common_name": "TRANDATE 100mg",
    "fr_drug_brand_name": "Trandate",
    "fr_drug_common_name": "Trandate",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123900,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6288,
      "drug_code": 43137,
      "updated_date": "2025-05-15T03:49:45-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8312804,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02213745",
      "brand_name": "ZOFRAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9432",
      "number_of_ais": "1",
      "ai_group_no": "0131120004"
    },
    "created_date": "2020-09-09T12:44:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02213745",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "discontinuation_date": "2021-08-26T00:00:00-04:00",
    "anticipated_discontinuation_date": "2021-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-09-23T15:11:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ZOFRAN",
    "en_drug_common_name": "ZOFRAN INJ 8MG AMPS 4ML 5'S",
    "fr_drug_brand_name": "ZOFRAN INJ 8MG AMPS 4ML 5'S",
    "fr_drug_common_name": "ZOFRAN",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "4ML X 5'S",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123906,
    "drug": {
      "current_status": "MARKETED",
      "id": 5036,
      "drug_code": 29543,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252780,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02106280",
      "brand_name": "TRANDATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "F6257",
      "number_of_ais": "1",
      "ai_group_no": "0116170003"
    },
    "created_date": "2020-09-09T12:47:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02106280",
    "company_name": "PALADIN LABS INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2020-09-14T00:00:00-04:00",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-11T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-11-05T15:38:58-05:00",
    "status": "resolved",
    "en_comments": "Product on allocation - Orders may not be shipped entirely",
    "fr_comments": "Produit en allocation - Les commandes ne seront peut-être pas livré au complet",
    "en_drug_brand_name": "TRANDATE",
    "en_drug_common_name": "Trandate",
    "fr_drug_brand_name": "Trandate",
    "fr_drug_common_name": "Trandate",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123914,
    "drug": {
      "current_status": "MARKETED",
      "id": 14106,
      "drug_code": 74136,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255094,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256134",
      "brand_name": "APO-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418001"
    },
    "created_date": "2020-09-09T12:56:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256134",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2020-10-11T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T12:29:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "APO-BISOPROLOL",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123921,
    "drug": {
      "current_status": "MARKETED",
      "id": 9564,
      "drug_code": 63181,
      "updated_date": "2025-12-03T00:30:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253708,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239700",
      "brand_name": "APO-DIVALPROEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996003"
    },
    "created_date": "2020-09-09T13:01:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239700",
    "company_name": "APOTEX INC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-26T12:25:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DIVALPROEX",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "APO-DIVALPROEX",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123927,
    "drug": {
      "current_status": "MARKETED",
      "id": 52151,
      "drug_code": 89791,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259958,
          "ingredient": {
            "id": 682,
            "ingredient_code": 10224,
            "en_name": "DOXYLAMINE SUCCINATE",
            "fr_name": "Succinate de doxylamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259957,
          "ingredient": {
            "id": 636,
            "ingredient_code": 5008,
            "en_name": "PYRIDOXINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de pyridoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413248",
      "brand_name": "APO-DOXYLAMINE/B6",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0213346001"
    },
    "created_date": "2020-09-09T13:05:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413248",
    "company_name": "APOTEX INC",
    "atc_number": "R06AA",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2020-11-06T00:00:00-05:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-02T14:34:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXYLAMINE/B6",
    "en_drug_common_name": "DOXYLAMINE",
    "fr_drug_brand_name": "APO-DOXYLAMINE",
    "fr_drug_common_name": "DOXYLAMINE",
    "en_ingredients": "DOXYLAMINE SUCCINATE\r\nPYRIDOXINE HYDROCHLORIDE",
    "fr_ingredients": "Succinate de doxylamine\r\nChlorhydrate de pyridoxine",
    "drug_strength": "10MG\r\n10MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123932,
    "drug": {
      "current_status": "MARKETED",
      "id": 2072,
      "drug_code": 14386,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251956,
          "ingredient": {
            "id": 1070,
            "ingredient_code": 1810,
            "en_name": "ENALAPRIL MALEATE",
            "fr_name": "Maléate d'énalapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02019884",
      "brand_name": "APO-ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76001",
      "number_of_ais": "1",
      "ai_group_no": "0117649003"
    },
    "created_date": "2020-09-09T13:08:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02019884",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-03-12T00:00:00-05:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2021-03-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-09T13:56:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ENALAPRIL TAB 5MG",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "APO-ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL MALEATE",
    "fr_ingredients": "Maléate d'énalapril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123939,
    "drug": {
      "current_status": "MARKETED",
      "id": 4292,
      "drug_code": 20239,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252690,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252689,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02195941",
      "brand_name": "APO-LEVOCARB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82543",
      "number_of_ais": "2",
      "ai_group_no": "0210315003"
    },
    "created_date": "2020-09-09T13:11:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02195941",
    "company_name": "APOTEX INC",
    "atc_number": "N04BA",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2020-09-27T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-21T17:13:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVOCARB-TAB 25MG/100MG",
    "en_drug_common_name": "LEVOCARB",
    "fr_drug_brand_name": "APO-LEVOCARB",
    "fr_drug_common_name": "LEVOCARB",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123944,
    "drug": {
      "current_status": "MARKETED",
      "id": 15610,
      "drug_code": 76294,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255598,
          "ingredient": {
            "id": 806,
            "ingredient_code": 7538,
            "en_name": "MEDROXYPROGESTERONE ACETATE",
            "fr_name": "Acétate de médroxyprogestérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277298",
      "brand_name": "AA-MEDROXY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106339006"
    },
    "created_date": "2020-09-09T13:13:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277298",
    "company_name": "APOTEX INC",
    "atc_number": "G03DA",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2020-12-11T00:00:00-05:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-07T13:46:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MEDROXY",
    "en_drug_common_name": "MEDROXY",
    "fr_drug_brand_name": "APO-MEDROXY",
    "fr_drug_common_name": "MEDROXY",
    "en_ingredients": "MEDROXYPROGESTERONE ACETATE",
    "fr_ingredients": "Acétate de médroxyprogestérone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123951,
    "drug": {
      "current_status": "DORMANT",
      "id": 21382,
      "drug_code": 83781,
      "updated_date": "2025-12-03T02:32:27-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368453,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02352559",
      "brand_name": "APO-MYCOPHENOLATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158001"
    },
    "created_date": "2020-09-09T13:17:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352559",
    "company_name": "APOTEX INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2020-12-04T00:00:00-05:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-07T13:49:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MYCOPHENOLATE",
    "en_drug_common_name": "MYCOPHENOLATE",
    "fr_drug_brand_name": "APO-MYCOPHENOLATE",
    "fr_drug_common_name": "MYCOPHENOLATE",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123954,
    "drug": {
      "current_status": "MARKETED",
      "id": 8016,
      "drug_code": 5222,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250723,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00592277",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60000",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2020-09-09T13:23:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00592277",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-10-02T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T12:38:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123957,
    "drug": {
      "current_status": "MARKETED",
      "id": 15962,
      "drug_code": 76745,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255700,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281791",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2020-09-09T13:27:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281791",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-12-18T00:00:00-05:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-17T23:16:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123960,
    "drug": {
      "current_status": "MARKETED",
      "id": 52255,
      "drug_code": 94843,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262297,
          "ingredient": {
            "id": 118,
            "ingredient_code": 10207,
            "en_name": "PHENYTOIN SODIUM",
            "fr_name": "Phénytoïne sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460912",
      "brand_name": "PHENYTOIN SODIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101375002"
    },
    "created_date": "2020-09-09T13:29:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460912",
    "company_name": "APOTEX INC",
    "atc_number": "N03AB",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-09-18T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-21T17:18:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PHENYTOIN SODIUM",
    "en_drug_common_name": "PHENYTOIN SODIUM",
    "fr_drug_brand_name": "APO-PHENYTOIN SODIUM",
    "fr_drug_common_name": "PHENYTOIN SODIUM",
    "en_ingredients": "PHENYTOIN SODIUM",
    "fr_ingredients": "Phénytoïne sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124002,
    "drug": {
      "current_status": "MARKETED",
      "id": 99677,
      "drug_code": 97441,
      "updated_date": "2020-04-03T06:53:58-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263810,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02484080",
      "brand_name": "MAR-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863006"
    },
    "created_date": "2020-09-09T19:04:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02484080",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2020-09-08T00:00:00-04:00",
    "estimated_end_date": "2021-11-15T00:00:00-05:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2022-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-20T15:56:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "MAR- DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "240MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124005,
    "drug": {
      "current_status": "MARKETED",
      "id": 99678,
      "drug_code": 97442,
      "updated_date": "2020-04-03T06:53:58-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263811,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02484099",
      "brand_name": "MAR-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863008"
    },
    "created_date": "2020-09-09T19:06:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02484099",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2020-09-08T00:00:00-04:00",
    "estimated_end_date": "2021-11-15T00:00:00-05:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2022-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-07-20T15:57:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "MAR - DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124032,
    "drug": {
      "current_status": "MARKETED",
      "id": 3454,
      "drug_code": 18742,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252365,
          "ingredient": {
            "id": 1132,
            "ingredient_code": 4179,
            "en_name": "CYCLOPENTOLATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cyclopentolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148382",
      "brand_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE CYCLOPENTOLATE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81016",
      "number_of_ais": "1",
      "ai_group_no": "0108675001"
    },
    "created_date": "2020-09-10T14:48:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148382",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "S01FA",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "actual_start_date": "2020-08-24T00:00:00-04:00",
    "actual_end_date": "2020-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-10-21T18:42:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%",
    "en_drug_common_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%",
    "fr_drug_brand_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%",
    "fr_drug_common_name": "MINIMS CYCLOPENTOLATE HYDROCHLORIDE 1%",
    "en_ingredients": "CYCLOPENTOLATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cyclopentolate",
    "drug_strength": "1%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124085,
    "drug": {
      "current_status": "MARKETED",
      "id": 25626,
      "drug_code": 88039,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259255,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395282",
      "brand_name": "TEVA-TEMOZOLOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781003"
    },
    "created_date": "2020-09-10T19:52:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395282",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-09T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:01-05:00",
    "status": "resolved",
    "en_comments": "Prev record 123093 resolved in error.",
    "en_drug_brand_name": "ACT TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE 100MG CAPSULES",
    "fr_drug_brand_name": "ACT-TEMOZOLOMIDE 100MG CAP",
    "fr_drug_common_name": "TEMOZOLOMIDE 100MG CAP",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124095,
    "drug": {
      "current_status": "MARKETED",
      "id": 18966,
      "drug_code": 80235,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256633,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316854",
      "brand_name": "TEVA-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618003"
    },
    "created_date": "2020-09-11T13:30:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316854",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2021-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-07T18:20:14-05:00",
    "status": "resolved",
    "en_comments": "Allocation to 100% of our market",
    "en_drug_brand_name": "TEVA-ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE 1MG FC TAB",
    "fr_drug_brand_name": "ACT-ROPINIROLE 1MG FC TAB",
    "fr_drug_common_name": "ROPINIROLE 1MG FC TAB",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124098,
    "drug": {
      "current_status": "MARKETED",
      "id": 19582,
      "drug_code": 80955,
      "updated_date": "2025-05-15T02:32:21-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256830,
          "ingredient": {
            "id": 3178,
            "ingredient_code": 13366,
            "en_name": "MEMANTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mémantine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324067",
      "brand_name": "ACT MEMANTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150423001"
    },
    "created_date": "2020-09-11T13:32:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324067",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06DX",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2021-01-31T00:00:00-05:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2021-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-14T20:04:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT MEMANTINE",
    "en_drug_common_name": "MEMANTINE 10MG FC TAB",
    "fr_drug_brand_name": "ACT-MEMANTINE 10MG FC TAB",
    "fr_drug_common_name": "MEMANTINE 10MG FC TAB",
    "en_ingredients": "MEMANTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mémantine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124101,
    "drug": {
      "current_status": "MARKETED",
      "id": 30004,
      "drug_code": 92058,
      "updated_date": "2025-05-15T02:34:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260922,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260921,
          "ingredient": {
            "id": 2418,
            "ingredient_code": 11458,
            "en_name": "LATANOPROST",
            "fr_name": "Latanoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02436256",
      "brand_name": "TEVA-LATANOPROST-TIMOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248501001"
    },
    "created_date": "2020-09-11T13:33:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436256",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2020-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-17T19:20:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LATANOPROST/TIMOLOL",
    "en_drug_common_name": "LATANOPROST-TIMOLOL 0.005%",
    "fr_drug_brand_name": "ACT-LATANOPROST-TIMOLOL 0.005%",
    "fr_drug_common_name": "LATANOPROST-TIMOLOL 0.005%",
    "en_ingredients": "LATANOPROST\r\nTIMOLOL",
    "fr_ingredients": "Latanoprost",
    "drug_strength": "50MCG\r\n5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "2.5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124104,
    "drug": {
      "current_status": "MARKETED",
      "id": 1470,
      "drug_code": 13180,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251731,
          "ingredient": {
            "id": 824,
            "ingredient_code": 1840,
            "en_name": "DOMPERIDONE",
            "fr_name": "Dompéridone (Maléate de dompéridone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01912070",
      "brand_name": "TEVA-DOMPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74486",
      "number_of_ais": "1",
      "ai_group_no": "0116957001"
    },
    "created_date": "2020-09-11T13:34:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01912070",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A03FA",
    "atc_description": "PROPULSIVES",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2020-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-17T19:21:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DOMPERIDONE",
    "en_drug_common_name": "DOMPERIDONE 10MG TAB",
    "fr_drug_brand_name": "TEVA-DOMPERIDONE 10MG TAB",
    "fr_drug_common_name": "DOMPERIDONE 10MG TAB",
    "en_ingredients": "DOMPERIDONE",
    "fr_ingredients": "DOMPERIDONE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124107,
    "drug": {
      "current_status": "MARKETED",
      "id": 1810,
      "drug_code": 13888,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251827,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00805009",
      "brand_name": "TEVA-TOPISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75364",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2020-09-11T13:36:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00805009",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-01T17:53:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TOPISONE",
    "en_drug_common_name": "TOPISONE 0.05% OINTMENT",
    "fr_drug_brand_name": "TEVA-TOPISONE 0.05% OINTMENT",
    "fr_drug_common_name": "TOPISONE 0.05% OINTMENT",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124110,
    "drug": {
      "current_status": "MARKETED",
      "id": 10626,
      "drug_code": 66208,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254024,
          "ingredient": {
            "id": 602,
            "ingredient_code": 1200,
            "en_name": "ZOPICLONE",
            "fr_name": "Zopiclone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242481",
      "brand_name": "TEVA-ZOPICLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122562001"
    },
    "created_date": "2020-09-11T13:38:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242481",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05CF",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2022-12-20T00:00:00-05:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-15T16:12:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ZOPICLONE",
    "en_drug_common_name": "ZOPICLONE 7.5MG TAB",
    "fr_drug_brand_name": "RATIO-ZOPICLONE 7.5MG TAB",
    "fr_drug_common_name": "ZOPICLONE 7.5MG TAB",
    "en_ingredients": "ZOPICLONE",
    "fr_ingredients": "Zopiclone",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124113,
    "drug": {
      "current_status": "MARKETED",
      "id": 7364,
      "drug_code": 49694,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253289,
          "ingredient": {
            "id": 1514,
            "ingredient_code": 2007,
            "en_name": "BROMAZEPAM",
            "fr_name": "Bromazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230585",
      "brand_name": "TEVA-BROMAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114488001"
    },
    "created_date": "2020-09-11T13:39:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230585",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2020-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-15T17:26:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BROMAZEPAM",
    "en_drug_common_name": "BROMAZEPAM 6MG TAB",
    "fr_drug_brand_name": "TEVA-BROMAZEPAM 6MG TAB",
    "fr_drug_common_name": "BROMAZEPAM 6MG TAB",
    "en_ingredients": "BROMAZEPAM",
    "fr_ingredients": "Bromazépam",
    "drug_strength": "6MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124116,
    "drug": {
      "current_status": "MARKETED",
      "id": 15572,
      "drug_code": 76242,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255583,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276747",
      "brand_name": "TEVA-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2020-09-11T13:40:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02276747",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2020-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-22T17:08:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE 10MG TAB",
    "fr_drug_brand_name": "TEVA-OLANZAPINE 10MG TAB",
    "fr_drug_common_name": "OLANZAPINE 10MG TAB",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124119,
    "drug": {
      "current_status": "MARKETED",
      "id": 8382,
      "drug_code": 579,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250157,
          "ingredient": {
            "id": 574,
            "ingredient_code": 10259,
            "en_name": "CHLORPHENIRAMINE MALEATE",
            "fr_name": "Maléate de chlorphéniramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00021288",
      "brand_name": "TEVA-PHENIRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23698",
      "number_of_ais": "1",
      "ai_group_no": "0100615003"
    },
    "created_date": "2020-09-11T13:41:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00021288",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R06AB",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-10T00:00:00-04:00",
    "actual_end_date": "2020-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-24T17:38:53-04:00",
    "status": "resolved",
    "en_comments": "Reported in error",
    "en_drug_brand_name": "TEVA-PHENIRAM",
    "en_drug_common_name": "PHENIRAM 4MG TAB",
    "fr_drug_brand_name": "TEVA-PHENIRAM 4MG TAB",
    "fr_drug_common_name": "PHENIRAM 4MG TAB",
    "en_ingredients": "CHLORPHENIRAMINE MALEATE",
    "fr_ingredients": "Maléate de chlorphéniramine",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124122,
    "drug": {
      "current_status": "MARKETED",
      "id": 13096,
      "drug_code": 72483,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8254770,
          "ingredient": {
            "id": 2534,
            "ingredient_code": 11710,
            "en_name": "BRIMONIDINE TARTRATE",
            "fr_name": "Tartrate de brimonidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02248151",
      "brand_name": "ALPHAGAN P",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131859003"
    },
    "created_date": "2020-09-11T13:47:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248151",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01EA",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2020-09-14T00:00:00-04:00",
    "actual_start_date": "2020-09-17T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALPHAGAN P",
    "en_drug_common_name": "Alphagan P",
    "fr_drug_brand_name": "Alphagan P",
    "fr_drug_common_name": "Alphagan P",
    "en_ingredients": "BRIMONIDINE TARTRATE",
    "fr_ingredients": "Tartrate de brimonidine",
    "drug_strength": "0.15%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5 ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124153,
    "drug": {
      "current_status": "MARKETED",
      "id": 56380,
      "drug_code": 95926,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262886,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470284",
      "brand_name": "AURO-METRONIDAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102572003"
    },
    "created_date": "2020-09-11T21:28:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470284",
    "company_name": "AURO PHARMA INC",
    "atc_number": "P01AB",
    "atc_description": "AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.",
    "actual_start_date": "2020-09-11T00:00:00-04:00",
    "actual_end_date": "2020-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-28T20:53:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-METRONIDAZOLE",
    "en_drug_common_name": "Clindamycin",
    "fr_drug_brand_name": "AURO-METRONIDAZOLE",
    "fr_drug_common_name": "Métronidazole",
    "en_ingredients": "METRONIDAZOLE",
    "fr_ingredients": "Métronidazole",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124156,
    "drug": {
      "current_status": "MARKETED",
      "id": 20988,
      "drug_code": 83126,
      "updated_date": "2025-05-15T02:32:37-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8257441,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02345846",
      "brand_name": "AURO-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938006"
    },
    "created_date": "2020-09-11T21:34:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02345846",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2020-09-11T00:00:00-04:00",
    "actual_end_date": "2021-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-01-29T17:44:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-TOPIRAMATE",
    "en_drug_common_name": "Topiramate",
    "fr_drug_brand_name": "AURO-TOPIRAMATE",
    "fr_drug_common_name": "Topiramate",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124196,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 99550,
      "drug_code": 97081,
      "updated_date": "2020-04-03T06:53:50-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8358010,
          "ingredient": {
            "id": 9897,
            "ingredient_code": 22910,
            "en_name": "OLARATUMAB",
            "fr_name": "OLARATUMAB"
          },
          "ingredient_supplied_ind": "I",
          "strength": "190",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "19",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02480271",
      "brand_name": "LARTRUVO",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0159610001"
    },
    "created_date": "2020-09-14T12:52:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02480271",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "L01XC",
    "discontinuation_date": "2020-09-25T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Lilly Canada’s Customer Response Centre 1-888-545-5972.",
    "fr_discontinuation_comments": "Lilly Canada’s Customer Response Centre 1-888-545-5972.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-10-05T18:05:40-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LARTRUVO",
    "en_drug_common_name": "OLARATUMAB",
    "fr_drug_brand_name": "LARTRUVO",
    "fr_drug_common_name": "OLARATUMAB",
    "en_ingredients": "OLARATUMAB",
    "fr_ingredients": "OLARATUMAB",
    "drug_strength": "190MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 Vial, 190 MG / 19 ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124238,
    "drug": {
      "current_status": "MARKETED",
      "id": 3938,
      "drug_code": 19589,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252514,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "112",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02171228",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 112MCG",
      "pediatric_flag": false,
      "accession_number": "81886",
      "number_of_ais": "1",
      "ai_group_no": "0107794019"
    },
    "created_date": "2020-09-14T17:25:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02171228",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-10-09T00:00:00-04:00",
    "estimated_end_date": "2020-12-08T00:00:00-05:00",
    "actual_start_date": "2020-10-09T00:00:00-04:00",
    "actual_end_date": "2020-11-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-27T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE SODIUM",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE SODIUM",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "112MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124241,
    "drug": {
      "current_status": "MARKETED",
      "id": 3950,
      "drug_code": 19598,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252519,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172127",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 150MCG",
      "pediatric_flag": false,
      "accession_number": "81895",
      "number_of_ais": "1",
      "ai_group_no": "0107794023"
    },
    "created_date": "2020-09-14T17:27:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172127",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-11-21T00:00:00-05:00",
    "estimated_end_date": "2020-12-15T00:00:00-05:00",
    "actual_start_date": "2020-11-21T00:00:00-05:00",
    "actual_end_date": "2020-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-09T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE SODIUM",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE SODIUM",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "150MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124246,
    "drug": {
      "current_status": "MARKETED",
      "id": 8134,
      "drug_code": 53868,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253431,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "137",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02233852",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 137MCG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107794013"
    },
    "created_date": "2020-09-14T17:30:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02233852",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-10-06T00:00:00-04:00",
    "estimated_end_date": "2020-11-24T00:00:00-05:00",
    "actual_start_date": "2020-10-09T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE SODIUM",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE SODIUM",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "137MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124251,
    "drug": {
      "current_status": "MARKETED",
      "id": 3954,
      "drug_code": 19600,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252521,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "175",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172135",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 175MCG",
      "pediatric_flag": false,
      "accession_number": "81897",
      "number_of_ais": "1",
      "ai_group_no": "0107794017"
    },
    "created_date": "2020-09-14T17:31:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172135",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-10-21T00:00:00-04:00",
    "estimated_end_date": "2020-11-03T00:00:00-05:00",
    "actual_start_date": "2020-10-09T00:00:00-04:00",
    "actual_end_date": "2020-11-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-03T15:07:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE SODIUM",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE SODIUM",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "175MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124275,
    "drug": {
      "current_status": "MARKETED",
      "id": 19774,
      "drug_code": 81116,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256905,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325802",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2020-09-15T12:42:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325802",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2020-11-27T00:00:00-05:00",
    "actual_start_date": "2020-09-14T00:00:00-04:00",
    "actual_end_date": "2020-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-11-28T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "PRAMIPEXOLE 0.25",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124288,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18682,
      "drug_code": 79952,
      "updated_date": "2025-05-15T04:13:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8345806,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314002",
      "brand_name": "SANDOZ QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2020-09-15T15:21:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02314002",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2020-09-15T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 2,
      "en_reason": "Raw material availability",
      "fr_reason": "Disponibilité des matières premières",
      "active": true
    },
    "updated_date": "2020-09-16T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ QUETIAPINE",
    "en_drug_common_name": "SANDOZ QUETIAPINE",
    "fr_drug_brand_name": "SANDOZ QUETIAPINE",
    "fr_drug_common_name": "SANDOZ QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124301,
    "drug": {
      "current_status": "MARKETED",
      "id": 12504,
      "drug_code": 71198,
      "updated_date": "2025-12-03T00:30:52-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254599,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02246969",
      "brand_name": "SANDOZ ESTRADIOL DERM 100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457037"
    },
    "created_date": "2020-09-15T15:33:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246969",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-09-11T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-26T12:41:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ESTRADIOL DERM 100",
    "en_drug_common_name": "SANDOZ ESTRADIOL DERM 100",
    "fr_drug_brand_name": "SANDOZ ESTRADIOL DERM 100",
    "fr_drug_common_name": "SANDOZ ESTRADIOL DERM 100",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "24H 8TTS CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124304,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10658,
      "drug_code": 66276,
      "updated_date": "2025-05-15T04:01:56-04:00",
      "company": {
        "id": 140,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 4835,
        "mfr_code": "ODN07",
        "name": "ODAN LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "325 STILLVIEW AVENUE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 2Y6",
        "post_office_box": "",
        "contact_information": "info@odanlab.com\r\nTel.: 1-800-387-9342\r\nFax: 1-800-329-6326"
      },
      "drug_ingredients": [
        {
          "id": 8332520,
          "ingredient": {
            "id": 48,
            "ingredient_code": 7532,
            "en_name": "HYDROCORTISONE",
            "fr_name": "Hydrocortisone (Extrait corticosurrénalien)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8332519,
          "ingredient": {
            "id": 2016,
            "ingredient_code": 7053,
            "en_name": "DIBUCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de dibucaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8332518,
          "ingredient": {
            "id": 1292,
            "ingredient_code": 8626,
            "en_name": "FRAMYCETIN SULFATE",
            "fr_name": "Sulfate de framycétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8332517,
          "ingredient": {
            "id": 2018,
            "ingredient_code": 9068,
            "en_name": "ESCULIN",
            "fr_name": "Esculine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242528",
      "brand_name": "ODAN PROCTOMYXIN HC SUPPOSITORIES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0404592002"
    },
    "created_date": "2020-09-15T15:35:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242528",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C05AA",
    "atc_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
    "estimated_end_date": "2020-10-16T00:00:00-04:00",
    "actual_start_date": "2020-09-11T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T12:09:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PROCTOMYXIN HC SUPPOSITORIES",
    "en_drug_common_name": "SANDOZ PROCTOMYXIN HC SUPPOSITOIRES",
    "fr_drug_brand_name": "SANDOZ PROCTOMYXIN HC SUPPOSITOIRES",
    "fr_drug_common_name": "SANDOZ PROCTOMYXIN HC SUPPOSITOIRES",
    "en_ingredients": "DIBUCAINE HYDROCHLORIDE\r\nESCULIN\r\nHYDROCORTISONE\r\nFRAMYCETIN SULFATE",
    "fr_ingredients": "Chlorhydrate de dibucaïne\r\nEsculine\r\nHydrocortisone\r\nSulfate de framycétine",
    "drug_strength": "5MG\r\n10MG\r\n5MG\r\n10MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "12SUP ST V1 CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124311,
    "drug": {
      "current_status": "MARKETED",
      "id": 31874,
      "drug_code": 94357,
      "updated_date": "2025-12-03T00:33:09-05:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8262049,
          "ingredient": {
            "id": 4090,
            "ingredient_code": 22629,
            "en_name": "EMPAGLIFLOZIN",
            "fr_name": "EMPAGLIFLOZINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262048,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456575",
      "brand_name": "SYNJARDY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0258370001"
    },
    "created_date": "2020-09-15T20:21:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456575",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2020-09-16T00:00:00-04:00",
    "estimated_end_date": "2020-11-09T00:00:00-05:00",
    "actual_start_date": "2020-09-21T00:00:00-04:00",
    "actual_end_date": "2020-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNJARDY",
    "en_drug_common_name": "Synjardy 5/500mg, 6x10s Tablets",
    "fr_drug_brand_name": "SYNJARDY",
    "fr_drug_common_name": "Synjardy 5/500mg, 6x10",
    "en_ingredients": "EMPAGLIFLOZIN\r\nMETFORMIN HYDROCHLORIDE",
    "fr_ingredients": "EMPAGLIFLOZINE\r\nChlorhydrate de metformine",
    "drug_strength": "5MG\r\n500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister Pack 6x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124327,
    "drug": {
      "current_status": "MARKETED",
      "id": 730,
      "drug_code": 11642,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251561,
          "ingredient": {
            "id": 472,
            "ingredient_code": 10114,
            "en_name": "ISOPROTERENOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'isoprotérénol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00897639",
      "brand_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72462",
      "number_of_ais": "1",
      "ai_group_no": "0101873001"
    },
    "created_date": "2020-09-16T14:15:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00897639",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "actual_start_date": "2020-11-26T00:00:00-05:00",
    "actual_end_date": "2022-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-03-11T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
    "fr_drug_brand_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "ISOPROTERENOL HYDROCHLORIDE INJECTION USP",
    "en_ingredients": "ISOPROTERENOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'isoprotérénol",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée\r\nIntramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 X 1mLa",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124334,
    "drug": {
      "current_status": "MARKETED",
      "id": 1556,
      "drug_code": 13370,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251760,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02010909",
      "brand_name": "PROSCAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74734",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2020-09-16T21:38:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02010909",
    "company_name": "MERCK CANADA INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2020-10-01T00:00:00-04:00",
    "estimated_end_date": "2020-11-06T00:00:00-05:00",
    "actual_start_date": "2020-10-02T00:00:00-04:00",
    "actual_end_date": "2020-11-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-11-04T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PROSCAR",
    "en_drug_common_name": "Finasteride tablets",
    "fr_drug_brand_name": "PROSCAR",
    "fr_drug_common_name": "comprimés de finastéride",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124344,
    "drug": {
      "current_status": "MARKETED",
      "id": 53515,
      "drug_code": 95539,
      "updated_date": "2025-05-15T02:35:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262664,
          "ingredient": {
            "id": 3520,
            "ingredient_code": 20430,
            "en_name": "DESVENLAFAXINE",
            "fr_name": "Desvenlafaxine (Succinate de desvenlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466988",
      "brand_name": "APO-DESVENLAFAXINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152509001"
    },
    "created_date": "2020-09-17T12:25:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466988",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-10-09T00:00:00-04:00",
    "actual_start_date": "2020-09-14T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T13:01:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESVENLAFAXINE",
    "en_drug_common_name": "DESVENLAFAXINE",
    "fr_drug_brand_name": "APO-DESVENLAFAXINE",
    "fr_drug_common_name": "DESVENLAFAXINE",
    "en_ingredients": "DESVENLAFAXINE",
    "fr_ingredients": "DESVENLAFAXINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124347,
    "drug": {
      "current_status": "MARKETED",
      "id": 9562,
      "drug_code": 63180,
      "updated_date": "2025-12-03T00:30:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253707,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239699",
      "brand_name": "APO-DIVALPROEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996001"
    },
    "created_date": "2020-09-17T12:33:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239699",
    "company_name": "APOTEX INC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-09-22T00:00:00-04:00",
    "actual_start_date": "2020-09-14T00:00:00-04:00",
    "actual_end_date": "2020-09-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-25T14:19:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DIVALPROEX",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "APO-DIVALPROEX",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124350,
    "drug": {
      "current_status": "MARKETED",
      "id": 754,
      "drug_code": 11728,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251563,
          "ingredient": {
            "id": 240,
            "ingredient_code": 4007,
            "en_name": "GLYBURIDE",
            "fr_name": "Glyburide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01913654",
      "brand_name": "APO GLYBURIDE TAB 2.5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72608",
      "number_of_ais": "1",
      "ai_group_no": "0108708002"
    },
    "created_date": "2020-09-17T12:40:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01913654",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-10-04T00:00:00-04:00",
    "actual_start_date": "2020-09-14T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T12:30:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO GLYBURIDE TAB 2.5MG",
    "en_drug_common_name": "GLYBURIDE",
    "fr_drug_brand_name": "APO-GLYBURIDE",
    "fr_drug_common_name": "GLYBURIDE",
    "en_ingredients": "GLYBURIDE",
    "fr_ingredients": "Glyburide",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124353,
    "drug": {
      "current_status": "MARKETED",
      "id": 11738,
      "drug_code": 69062,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254360,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245058",
      "brand_name": "APO-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2020-09-17T12:46:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245058",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-10-02T00:00:00-04:00",
    "actual_start_date": "2020-09-14T00:00:00-04:00",
    "actual_end_date": "2020-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-28T15:27:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "APO-OMEPRAZOLE",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124356,
    "drug": {
      "current_status": "MARKETED",
      "id": 11072,
      "drug_code": 67227,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254159,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243324",
      "brand_name": "APO-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258001"
    },
    "created_date": "2020-09-17T12:49:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243324",
    "company_name": "APOTEX INC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2020-10-09T00:00:00-04:00",
    "actual_start_date": "2020-09-14T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T13:02:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "APO-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124359,
    "drug": {
      "current_status": "MARKETED",
      "id": 22344,
      "drug_code": 84741,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257998,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362406",
      "brand_name": "APO-TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED-RELEASE TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2020-09-17T12:52:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362406",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2021-02-26T00:00:00-05:00",
    "actual_start_date": "2020-09-14T00:00:00-04:00",
    "actual_end_date": "2021-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-23T13:49:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN",
    "fr_drug_brand_name": "APO-TAMSULOSIN",
    "fr_drug_common_name": "TAMSULOSIN",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124366,
    "drug": {
      "current_status": "MARKETED",
      "id": 3868,
      "drug_code": 19442,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252489,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "236",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252488,
          "ingredient": {
            "id": 160,
            "ingredient_code": 6337,
            "en_name": "POTASSIUM PHOSPHATE MONOBASIC",
            "fr_name": "Phosphate de potassium monobasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "224",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139545",
      "brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81739",
      "number_of_ais": "2",
      "ai_group_no": "0207483001"
    },
    "created_date": "2020-09-17T14:06:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139545",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2020-11-02T00:00:00-05:00",
    "estimated_end_date": "2020-12-21T00:00:00-05:00",
    "actual_end_date": "2021-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-26T20:01:17-05:00",
    "status": "resolved",
    "en_comments": "Potassium Phosphates Injection, USP, 3 mmol/mL, Phosphorus SD Vial, 50 mL we will be placing the following products on 50% allocation effective today, Tuesday, September 15, 2020.\r\nUPDATE 10/30: Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Potassium Phosphates Injection, USP, 3 mmol/mL Phosphorous SD Vial 50 mL. Estimated Stockout Date November 2, 2020 Estimated Availability Date December 4, 2020 Our Potassium Phosphates Injection, USP, 3 mmol/mL Phosphorous SD Vial 15 mL vials will be placed on 100% allocation and allocations will be increased to cover the 50 mL demand on a 3:1 ratio (three 15mL vials to one 50mL vial).\r\nUPDATE 11/25: We will also be extending the backorder on our Potassium Phosphates Injection, USP 3 mmol/mL Phosphorus\r\nSD Vial 50 mL until December 21, 2020.\r\nUPDATE We are also pleased to advise that replenishment inventories of our Potassium Phosphates Injection, USP 3\r\nmmol/mL Phosphorus SD Vial 50 mL have been released and the product will be placed on 100% allocation,\r\neffective December 22, 2020. Please note that Potassium Phosphates Injection, USP 3 mmol/mL Phosphorus\r\nSD Vial 15 mL will remain on 100% allocation.",
    "fr_comments": "Phosphates de potassium injectable, USP, 3 mmol/mL, Fioles DU de phosphore, 50 mL nous allons mettre les produits suivants sous 50% allocation, à compter du mardi 15 septembre 2020. UPDATE 10/30: Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison d’un retard de production, nous allons éprouver une interruption d’approvisionnement qui va toucher notre préparation de Phosphates de potassium injectables, USP, à 3 mmol/mL en fioles DU de 50 mL  Date estimative d’épuisement des stocks 2 novembre 2020 Date estimative de disponibilité 4 décembre 2020 Notre présentation de Phosphates de potassium injectable, USP, à 3 mmol/mL de phosphore en fioles DU de 15 mL sera mise sous allocation à 100 % et les allocations seront augmentées pour couvrir la demande du 50 mL selon un rapport de 3:1 (trois fioles de 15 mL pour une fiole de 50 mL). UPDATE 11/25: Nous devons également subir une prolongation de rupture de stock touchant notre présentation de Phosphates de\r\npotassium injectables, USP à 3 mmol/mL en fioles DU de phosphore de 50 mL jusqu’au 21 décembre 2020.\r\nUPDATE\r\nJ’ai également le plaisir de vous informer que les stocks de réapprovisionnement de notre préparation de Phosphates de\r\npotassium injectables, USP à 3 mmol/mL de phosphore en fioles DU de 50 mL sont autorisés pour mise en marché et que\r\nle produit est mis sous allocation de 100 %, dès le 22 décembre 2020. Veuillez noter que notre préparation de Phosphates de\r\npotassium injectables, USP à 3 mmol/mL de phosphore en fioles DU de 15 mL demeurera sous allocation à 100 %.",
    "en_drug_brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
    "en_drug_common_name": "Potassium Phosphates Injection",
    "fr_drug_brand_name": "Phosphates de potassium injectable",
    "fr_drug_common_name": "Phosphates de potassium injectable",
    "en_ingredients": "POTASSIUM PHOSPHATE MONOBASIC\r\nPOTASSIUM PHOSPHATE DIBASIC",
    "fr_ingredients": "Phosphate de potassium monobasique\r\nPhosphate de potassium dibasique",
    "drug_strength": "224MG\r\n236MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124369,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 65431,
      "drug_code": 97680,
      "updated_date": "2025-12-03T01:33:55-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8358254,
          "ingredient": {
            "id": 800,
            "ingredient_code": 9197,
            "en_name": "SODIUM BICARBONATE",
            "fr_name": "Bicarbonate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "42",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02486628",
      "brand_name": "SODIUM BICARBONATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104153008"
    },
    "created_date": "2020-09-17T14:10:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02486628",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2020-09-15T00:00:00-04:00",
    "actual_end_date": "2020-12-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-26T20:12:22-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada Ltd. regrets to advise that due to unforeseen circumstances, our Sodium Bicarbonate Injection, USP, 4.2%, 2.5 mEq (mmol), 5 mL Vial is on backorder, effective today. We are working with our production site to expedite receipt of our next shipment.\r\nUPDATE\r\nAvailable 12/05/2020",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison de circonstances imprévues, notre préparation de Bicarbonate de sodium injectable, USP, à 4,2 %, 2,5 mEq (mmol) en fioles de 5 mL est en rupture de stock à partir d’aujourd’hui même. Nous travaillons avec notre site de production afin d’accélérer la réception de notre prochain envoi.\r\nUPDATE\r\nAvailable 12/05/2020",
    "en_drug_brand_name": "SODIUM BICARBONATE INJECTION, USP",
    "en_drug_common_name": "Sodium Bicarbonate Injection",
    "fr_drug_brand_name": "Bicarbonate de sodium injectable",
    "fr_drug_common_name": "Bicarbonate de sodium injectable",
    "en_ingredients": "SODIUM BICARBONATE",
    "fr_ingredients": "Bicarbonate de sodium",
    "drug_strength": "42MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "4.2%, 2.5 mEq (mmol), 5 mL Vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124425,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 61770,
      "drug_code": 96293,
      "updated_date": "2025-05-15T04:25:34-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357744,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02473542",
      "brand_name": "M-RANITIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150001"
    },
    "created_date": "2020-09-17T19:28:29-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02473542",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2020-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-17T19:44:32-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "M-RANITIDINE",
    "en_drug_common_name": "Ranitidine",
    "fr_drug_brand_name": "M-Ranitidine",
    "fr_drug_common_name": "Ranitidine",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "Ranitidine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124442,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 61768,
      "drug_code": 96292,
      "updated_date": "2025-05-15T04:25:34-04:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357743,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02473534",
      "brand_name": "M-RANITIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2020-09-17T19:50:31-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02473534",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2020-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-17T19:53:06-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "M-RANITIDINE",
    "en_drug_common_name": "Ranitidine",
    "fr_drug_brand_name": "M-Ranitidine",
    "fr_drug_common_name": "Ranitidine",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "Ranitidine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124468,
    "drug": {
      "current_status": "MARKETED",
      "id": 15398,
      "drug_code": 75966,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255512,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274205",
      "brand_name": "TEVA-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2020-09-17T20:57:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274205",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-09-16T00:00:00-04:00",
    "actual_end_date": "2020-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-17T19:21:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM 750MG FC TAB",
    "fr_drug_brand_name": "ACT-LEVETIRACETAM 750MG FC TAB",
    "fr_drug_common_name": "LEVETIRACETAM 750MG FC TAB",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124471,
    "drug": {
      "current_status": "MARKETED",
      "id": 1594,
      "drug_code": 13437,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251765,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01910272",
      "brand_name": "TEVA-CLOBETASOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74824",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2020-09-17T20:58:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01910272",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2021-01-31T00:00:00-05:00",
    "actual_start_date": "2020-09-16T00:00:00-04:00",
    "actual_end_date": "2020-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-17T19:22:12-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOBETASOL",
    "en_drug_common_name": "CLOBETASOL 0.05% CREAM",
    "fr_drug_brand_name": "TEVA-CLOBETASOL 0.05% CREAM",
    "fr_drug_common_name": "CLOBETASOL 0.05% CREAM",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "450g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124474,
    "drug": {
      "current_status": "MARKETED",
      "id": 28154,
      "drug_code": 90301,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260230,
          "ingredient": {
            "id": 3336,
            "ingredient_code": 19840,
            "en_name": "RASAGILINE",
            "fr_name": "Rasagiline (Mésylate de rasagiline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418444",
      "brand_name": "TEVA-RASAGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151662002"
    },
    "created_date": "2020-09-17T20:59:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BD",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-16T00:00:00-04:00",
    "actual_end_date": "2020-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-26T21:13:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RASAGILINE",
    "en_drug_common_name": "RASAGILINE 1MG TAB",
    "fr_drug_brand_name": "TEVA-RASAGILINE 1MG TAB",
    "fr_drug_common_name": "RASAGILINE 1MG TAB",
    "en_ingredients": "RASAGILINE",
    "fr_ingredients": "RASAGILINE",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124477,
    "drug": {
      "current_status": "MARKETED",
      "id": 7720,
      "drug_code": 5072,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250704,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00342092",
      "brand_name": "TEVA-CEPHALEXIN 250",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59603",
      "number_of_ais": "1",
      "ai_group_no": "0105911002"
    },
    "created_date": "2020-09-17T21:00:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00342092",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-16T00:00:00-04:00",
    "actual_end_date": "2020-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-12T18:43:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN 250",
    "en_drug_common_name": "CEPHALEXIN SUSP 250MG/5ML",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN SUSP 250MG/5ML",
    "fr_drug_common_name": "CEPHALEXIN SUSP 250MG/5ML",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "150ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124480,
    "drug": {
      "current_status": "MARKETED",
      "id": 8966,
      "drug_code": 6136,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250866,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00637750",
      "brand_name": "TEVA-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62378",
      "number_of_ais": "1",
      "ai_group_no": "0110731002"
    },
    "created_date": "2020-09-17T21:02:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00637750",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-09-16T00:00:00-04:00",
    "actual_end_date": "2020-11-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-19T14:23:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LORAZEPAM",
    "en_drug_common_name": "LORAZEPAM 2MG TAB",
    "fr_drug_brand_name": "TEVA-LORAZEPAM 2MG TAB",
    "fr_drug_common_name": "LORAZEPAM 2MG TAB",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124490,
    "drug": {
      "current_status": "MARKETED",
      "id": 12374,
      "drug_code": 70814,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8254556,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246624",
      "brand_name": "COVERSYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127178003"
    },
    "created_date": "2020-09-18T13:27:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246624",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-09-28T00:00:00-04:00",
    "actual_start_date": "2020-09-17T00:00:00-04:00",
    "actual_end_date": "2020-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-09-24T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "The expiry date of the available stock is less that 9 month (02/2021) which is not acceptable by our clients",
    "fr_comments": "la date de péremption du stock disponible est inférieure à 9 mois ce qui n'est pas acceptable par nos clients.",
    "en_drug_brand_name": "COVERSYL",
    "en_drug_common_name": "COVERSYL",
    "fr_drug_brand_name": "coversyl",
    "fr_drug_common_name": "coversyl",
    "en_ingredients": "PERINDOPRIL ERBUMINE",
    "fr_ingredients": "Périndopril erbumine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124532,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1866,
      "drug_code": 1398,
      "updated_date": "2025-12-03T00:59:10-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8271819,
          "ingredient": {
            "id": 876,
            "ingredient_code": 7487,
            "en_name": "TESTOSTERONE CYPIONATE",
            "fr_name": "Cypionate de testosterone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00030783",
      "brand_name": "DEPO-TESTOSTERONE INJ 100MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "39740",
      "number_of_ais": "1",
      "ai_group_no": "0106401001"
    },
    "created_date": "2020-09-18T16:14:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00030783",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03BA",
    "atc_description": "ANDROGENS",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-10-15T17:14:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEPO-TESTOSTERONE INJ 100MG/ML",
    "en_drug_common_name": "DEPO-TESTOSTERONE",
    "fr_drug_brand_name": "DEPO-TESTOSTERONE",
    "fr_drug_common_name": "DEPO-TESTOSTERONE",
    "en_ingredients": "TESTOSTERONE CYPIONATE",
    "fr_ingredients": "Cypionate de testosterone",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 x 10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124539,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 61290,
      "drug_code": 97615,
      "updated_date": "2025-05-15T04:26:19-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8358211,
          "ingredient": {
            "id": 14561,
            "ingredient_code": 8045,
            "en_name": "THALLIUM CHLORIDE",
            "fr_name": "Chlorure de thallium (TI 201)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "Not Applicable/non applicable",
      "brand_name": "THALLOUS CHLORIDE TI 201 INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152598004"
    },
    "created_date": "2020-09-18T18:04:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485915",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V09GX",
    "estimated_end_date": "2020-09-20T00:00:00-04:00",
    "actual_start_date": "2020-09-15T00:00:00-04:00",
    "actual_end_date": "2020-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-21T16:18:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "THALLOUS CHLORIDE TI 201 INJECTION",
    "en_drug_common_name": "Thallous Chloride TI 201",
    "fr_drug_brand_name": "Thallous Chloride TI 201 Injection",
    "fr_drug_common_name": "Thallous Chloride TI 201",
    "en_ingredients": "THALLIUM CHLORIDE",
    "fr_ingredients": "Thallous Chloride (Tl-201)",
    "drug_strength": "37MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "8.8 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124542,
    "drug": {
      "current_status": "MARKETED",
      "id": 61160,
      "drug_code": 87259,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8258910,
          "ingredient": {
            "id": 20091,
            "ingredient_code": 21321,
            "en_name": "IOBENGUANE 123 I",
            "fr_name": "IOBENGUANE 123 I"
          },
          "ingredient_supplied_ind": "I",
          "strength": "74",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02387034",
      "brand_name": "ADREVIEW",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153180001"
    },
    "created_date": "2020-09-18T18:13:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387034",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V09IX",
    "estimated_end_date": "2020-09-20T00:00:00-04:00",
    "actual_start_date": "2020-09-15T00:00:00-04:00",
    "actual_end_date": "2020-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-21T16:18:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ADREVIEW",
    "en_drug_common_name": "Iobenguane (123I) Injection",
    "fr_drug_brand_name": "AdreView",
    "fr_drug_common_name": "iobenguane (123I) injectable",
    "en_ingredients": "IOBENGUANE 123 I",
    "fr_ingredients": "iobenguane 123 I",
    "drug_strength": "74MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124563,
    "drug": {
      "current_status": "MARKETED",
      "id": 6200,
      "drug_code": 42952,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253011,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8253010,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02197502",
      "brand_name": "SELECT 1/35 (21-DAY)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9181",
      "number_of_ais": "2",
      "ai_group_no": "0210010002"
    },
    "created_date": "2020-09-18T22:24:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02197502",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2021-02-01T00:00:00-05:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2021-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-02T13:44:48-05:00",
    "status": "resolved",
    "en_comments": "Recovery expected during Feb 2021.",
    "fr_comments": "Disponibilité prévue en février 2021.",
    "en_drug_brand_name": "SELECT 1/35 (21-DAY)",
    "en_drug_common_name": "SELECT 21",
    "fr_drug_brand_name": "SELECT 1/35 (21-DAY)",
    "fr_drug_common_name": "SELECT 21",
    "en_ingredients": "NORETHINDRONE\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Noréthindrone\r\nÉthinylestradiol",
    "drug_strength": "1.0MG\r\n0.035MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "21's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124566,
    "drug": {
      "current_status": "MARKETED",
      "id": 6166,
      "drug_code": 42890,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253000,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252999,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252998,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252997,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02187116",
      "brand_name": "SYNPHASIC 28 TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9075",
      "number_of_ais": "4",
      "ai_group_no": "0414813001"
    },
    "created_date": "2020-09-18T22:27:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187116",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "G03AB",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2021-02-22T00:00:00-05:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2021-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-23T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Recovery expected during Feb 2021.",
    "fr_comments": "Disponibilité prévue en février 2021.",
    "en_drug_brand_name": "SYNPHASIC 28 TABLETS",
    "en_drug_common_name": "SYNPHASIC 28",
    "fr_drug_brand_name": "SYNPHASIC 28",
    "fr_drug_common_name": "SYNPHASIC 28",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nNORETHINDRONE\r\nNORETHINDRONE",
    "fr_ingredients": "Éthinylestradiol\r\nNoréthindrone\r\nNoréthindrone",
    "drug_strength": "0.035MG\r\n0.5MG\r\n1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124589,
    "drug": {
      "current_status": "MARKETED",
      "id": 14450,
      "drug_code": 74714,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255207,
          "ingredient": {
            "id": 954,
            "ingredient_code": 1205,
            "en_name": "DICLOFENAC POTASSIUM",
            "fr_name": "Diclofénac potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261774",
      "brand_name": "SANDOZ DICLOFENAC RAPIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122516001"
    },
    "created_date": "2020-09-21T15:17:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261774",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-10-26T12:41:57-04:00",
    "status": "resolved",
    "en_comments": "Competitive BO",
    "fr_comments": "BO compétitif",
    "en_drug_brand_name": "SANDOZ DICLOFENAC RAPIDE",
    "en_drug_common_name": "SANDOZ DICLOFENAC RAPIDE",
    "fr_drug_brand_name": "SANDOZ DICLOFENAC RAPIDE",
    "fr_drug_common_name": "SANDOZ DICLOFENAC RAPIDE",
    "en_ingredients": "DICLOFENAC POTASSIUM",
    "fr_ingredients": "Diclofénac potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100SCT BO V1 CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124592,
    "drug": {
      "current_status": "MARKETED",
      "id": 23924,
      "drug_code": 86585,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258611,
          "ingredient": {
            "id": 2882,
            "ingredient_code": 12126,
            "en_name": "ENTACAPONE",
            "fr_name": "Entacapone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380005",
      "brand_name": "SANDOZ ENTACAPONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143623001"
    },
    "created_date": "2020-09-21T15:25:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380005",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N04BX",
    "atc_description": "DOPAMINERGIC AGENTS",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-09-28T12:47:04-04:00",
    "status": "resolved",
    "en_comments": "Delay in release",
    "fr_comments": "Délai de relâche",
    "en_drug_brand_name": "SANDOZ ENTACAPONE",
    "en_drug_common_name": "SANDOZ ENTACAPONE",
    "fr_drug_brand_name": "SANDOZ ENTACAPONE",
    "fr_drug_common_name": "SANDOZ ENTACAPONE",
    "en_ingredients": "ENTACAPONE",
    "fr_ingredients": "Entacapone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO V1 CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124600,
    "drug": {
      "current_status": "MARKETED",
      "id": 20566,
      "drug_code": 82301,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257274,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257273,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337428",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086001"
    },
    "created_date": "2020-09-21T15:30:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337428",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-27T14:23:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "en_ingredients": "IRBESARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Irbésartan\r\nHydrochlorothiazide",
    "drug_strength": "150MG\r\n12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124603,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23758,
      "drug_code": 86416,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8351136,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02378345",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE VANCOMYCINE POUR INJECTION, USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315008"
    },
    "created_date": "2020-09-21T15:31:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378345",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J01XA",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2020-09-30T00:00:00-04:00",
    "actual_end_date": "2021-02-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-04T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "Vancomycin Hydrochloride for Injection, USP",
    "fr_drug_brand_name": "Chlorhydrate de vancomycine injectable USP",
    "fr_drug_common_name": "Chlorhydrate de vancomycine injectable USP",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "Chlorhydrate de vancomycine",
    "drug_strength": "10G",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution\r\nPoudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 10g vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124606,
    "drug": {
      "current_status": "MARKETED",
      "id": 20566,
      "drug_code": 82301,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257274,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257273,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337428",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086001"
    },
    "created_date": "2020-09-21T15:32:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337428",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-27T14:23:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "en_ingredients": "IRBESARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Irbésartan\r\nHydrochlorothiazide",
    "drug_strength": "150MG\r\n12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124609,
    "drug": {
      "current_status": "MARKETED",
      "id": 20568,
      "drug_code": 82302,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257276,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257275,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337436",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086002"
    },
    "created_date": "2020-09-21T15:34:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337436",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-27T14:24:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "en_ingredients": "IRBESARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Irbésartan\r\nHydrochlorothiazide",
    "drug_strength": "300MG\r\n12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124612,
    "drug": {
      "current_status": "MARKETED",
      "id": 20568,
      "drug_code": 82302,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257276,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257275,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337436",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086002"
    },
    "created_date": "2020-09-21T15:36:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337436",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-27T14:24:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "en_ingredients": "IRBESARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Irbésartan\r\nHydrochlorothiazide",
    "drug_strength": "300MG\r\n12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124615,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13672,
      "drug_code": 73510,
      "updated_date": "2025-05-15T04:08:20-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8339737,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02250306",
      "brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
      "brand_name_fr": "CEFTRIAXONE SODIQUE POUR INJECTION BP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292002"
    },
    "created_date": "2020-09-21T15:37:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250306",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2020-09-30T00:00:00-04:00",
    "actual_end_date": "2021-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-04-06T05:00:08-04:00",
    "status": "resolved",
    "en_comments": "Item is discontinued.",
    "fr_comments": "L'item est discontinué.",
    "en_drug_brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
    "en_drug_common_name": "Ceftriaxone Sodium for Injection, BP",
    "fr_drug_brand_name": "Ceftriaxone sodique pour injection BP",
    "fr_drug_common_name": "Ceftriaxone sodique pour injection BP",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "Ceftriaxone sodique",
    "drug_strength": "2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10 x 2g vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124617,
    "drug": {
      "current_status": "MARKETED",
      "id": 20570,
      "drug_code": 82303,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257278,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257277,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337444",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2020-09-21T15:37:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-27T14:24:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "en_ingredients": "IRBESARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Irbésartan\r\nHydrochlorothiazide",
    "drug_strength": "300MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124621,
    "drug": {
      "current_status": "MARKETED",
      "id": 20570,
      "drug_code": 82303,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257278,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257277,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337444",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2020-09-21T15:38:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-27T14:25:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "SANDOZ IRBESARTAN HCT",
    "en_ingredients": "IRBESARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Irbésartan\r\nHydrochlorothiazide",
    "drug_strength": "300MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124713,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9852,
      "drug_code": 63981,
      "updated_date": "2025-05-15T03:59:44-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8329578,
          "ingredient": {
            "id": 2706,
            "ingredient_code": 11894,
            "en_name": "EPROSARTAN",
            "fr_name": "Éprosartan (Mésylate d'éprosartan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02240432",
      "brand_name": "TEVETEN",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137701002"
    },
    "created_date": "2020-09-22T14:08:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240432",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2020-11-25T00:00:00-05:00",
    "actual_end_date": "2020-11-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-11-10T12:36:20-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "TEVETEN",
    "en_drug_common_name": "EPROSARTAN",
    "fr_drug_brand_name": "TEVETEN",
    "fr_drug_common_name": "EPROSARTAN",
    "en_ingredients": "EPROSARTAN",
    "fr_ingredients": "EPROSARTAN",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "14x2",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124716,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11378,
      "drug_code": 67885,
      "updated_date": "2025-05-15T04:03:23-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8334247,
          "ingredient": {
            "id": 2706,
            "ingredient_code": 11894,
            "en_name": "EPROSARTAN",
            "fr_name": "Éprosartan (Mésylate d'éprosartan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02243942",
      "brand_name": "TEVETEN",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137701003"
    },
    "created_date": "2020-09-22T14:09:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243942",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2020-10-14T00:00:00-04:00",
    "estimated_end_date": "2020-10-28T00:00:00-04:00",
    "actual_end_date": "2020-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-09-29T14:31:55-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "TEVETEN",
    "en_drug_common_name": "EPROSARTAN",
    "fr_drug_brand_name": "TEVETEN",
    "fr_drug_common_name": "EPROSARTAN",
    "en_ingredients": "EPROSARTAN",
    "fr_ingredients": "EPROSARTAN",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x14",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124719,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13906,
      "drug_code": 73859,
      "updated_date": "2025-05-15T04:08:42-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8339991,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        },
        {
          "id": 8339990,
          "ingredient": {
            "id": 2706,
            "ingredient_code": 11894,
            "en_name": "EPROSARTAN",
            "fr_name": "Éprosartan (Mésylate d'éprosartan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02253631",
      "brand_name": "TEVETEN PLUS",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250121001"
    },
    "created_date": "2020-09-22T14:11:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02253631",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2020-09-30T00:00:00-04:00",
    "estimated_end_date": "2020-10-28T00:00:00-04:00",
    "actual_end_date": "2020-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-09-29T14:32:18-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "TEVETEN PLUS",
    "en_drug_common_name": "EPROSARTAN HYDROCHLOROTHIAZIDE",
    "fr_drug_brand_name": "TEVETEN PLUS",
    "fr_drug_common_name": "EPROSARTAN HYDROCHLOROTHIAZIDE",
    "en_ingredients": "EPROSARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "600MG\r\n12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x14",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124743,
    "drug": {
      "current_status": "MARKETED",
      "id": 20190,
      "drug_code": 81626,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257162,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257161,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330539",
      "brand_name": "TEVA-IRBESARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2020-09-22T18:35:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330539",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2021-07-31T00:00:00-04:00",
    "actual_start_date": "2020-09-16T00:00:00-04:00",
    "actual_end_date": "2021-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2021-03-04T16:08:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-IRBESARTAN HCTZ",
    "en_drug_common_name": "IRBESARTAN/HCTZ 300/25MG TABS",
    "fr_drug_brand_name": "TEVA-IRBESARTAN/HCTZ 300/25MG TABS",
    "fr_drug_common_name": "IRBESARTAN/HCTZ 300/25MG TABS",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124783,
    "drug": {
      "current_status": "MARKETED",
      "id": 13872,
      "drug_code": 73770,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254987,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02252767",
      "brand_name": "APO-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2020-09-22T20:01:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02252767",
    "company_name": "APOTEX INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2021-01-04T00:00:00-05:00",
    "actual_start_date": "2020-09-21T00:00:00-04:00",
    "actual_end_date": "2020-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-30T19:51:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL",
    "fr_drug_brand_name": "APO-CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124786,
    "drug": {
      "current_status": "MARKETED",
      "id": 7694,
      "drug_code": 50638,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253381,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231330",
      "brand_name": "APO-FLUVOXAMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122450001"
    },
    "created_date": "2020-09-22T20:05:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231330",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-11-03T00:00:00-05:00",
    "actual_start_date": "2020-09-21T00:00:00-04:00",
    "actual_end_date": "2020-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-02T14:35:44-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLUVOXAMINE TABLETS",
    "en_drug_common_name": "FLUVOXAMINE",
    "fr_drug_brand_name": "APO-FLUVOXAMINE",
    "fr_drug_common_name": "FLUVOXAMINE",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124789,
    "drug": {
      "current_status": "MARKETED",
      "id": 23432,
      "drug_code": 8602,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251107,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00751170",
      "brand_name": "APO-METOPROLOL (TYPE L)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67172",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2020-09-22T20:08:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00751170",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2020-12-04T00:00:00-05:00",
    "actual_start_date": "2020-09-21T00:00:00-04:00",
    "actual_end_date": "2020-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-23T14:01:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METOPROLOL (TYPE L)",
    "en_drug_common_name": "METOPROLOL",
    "fr_drug_brand_name": "APO-METOPROLOL L",
    "fr_drug_common_name": "METOPROLOL",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124792,
    "drug": {
      "current_status": "MARKETED",
      "id": 58730,
      "drug_code": 95848,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262845,
          "ingredient": {
            "id": 1122,
            "ingredient_code": 2097,
            "en_name": "PINAVERIUM BROMIDE",
            "fr_name": "Bromure de pinavérium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02469677",
      "brand_name": "PINAVERIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113429001"
    },
    "created_date": "2020-09-22T20:11:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469677",
    "company_name": "APOTEX INC",
    "atc_number": "A03AX",
    "atc_description": "DRUGS FOR FUNCTIONAL BOWEL DISORDERS",
    "estimated_end_date": "2020-10-01T00:00:00-04:00",
    "actual_start_date": "2020-09-21T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T13:00:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PINAVERIUM",
    "en_drug_common_name": "PINAVERIUM",
    "fr_drug_brand_name": "APO-PINAVERIUM",
    "fr_drug_common_name": "PINAVERIUM",
    "en_ingredients": "PINAVERIUM BROMIDE",
    "fr_ingredients": "Bromure de pinavérium",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124795,
    "drug": {
      "current_status": "MARKETED",
      "id": 66506,
      "drug_code": 98159,
      "updated_date": "2025-05-15T02:38:29-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8264364,
          "ingredient": {
            "id": 3760,
            "ingredient_code": 21066,
            "en_name": "PRUCALOPRIDE",
            "fr_name": "Prucalopride (Succinate de Prucalopride)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02491605",
      "brand_name": "APO-PRUCALOPRIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153049002"
    },
    "created_date": "2020-09-22T20:18:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02491605",
    "company_name": "APOTEX INC",
    "atc_number": "A06AX",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2020-11-29T00:00:00-05:00",
    "actual_start_date": "2020-09-21T00:00:00-04:00",
    "actual_end_date": "2020-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-27T20:29:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRUCALOPRIDE",
    "en_drug_common_name": "PRUCALOPRIDE",
    "fr_drug_brand_name": "APO-PRUCALOPRIDE",
    "fr_drug_common_name": "PRUCALOPRIDE",
    "en_ingredients": "PRUCALOPRIDE",
    "fr_ingredients": "PRUCALOPRIDE",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124798,
    "drug": {
      "current_status": "MARKETED",
      "id": 19722,
      "drug_code": 81078,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256881,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02325381",
      "brand_name": "APO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858005"
    },
    "created_date": "2020-09-22T20:24:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02325381",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-01-08T00:00:00-05:00",
    "actual_start_date": "2020-09-21T00:00:00-04:00",
    "actual_end_date": "2020-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-21T13:34:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "APO-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124826,
    "drug": {
      "current_status": "MARKETED",
      "id": 30708,
      "drug_code": 9276,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251141,
          "ingredient": {
            "id": 478,
            "ingredient_code": 7579,
            "en_name": "FLUOCINONIDE",
            "fr_name": "Fluocinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00716863",
      "brand_name": "LYDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68229",
      "number_of_ais": "1",
      "ai_group_no": "0106313001"
    },
    "created_date": "2020-09-22T21:17:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00716863",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2020-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-09-22T21:18:27-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LYDERM CREAM 0.05%",
    "en_drug_common_name": "LYDERM CREAM 0.05%",
    "fr_drug_brand_name": "LYDERM CREAM 0.05%",
    "fr_drug_common_name": "LYDERM CREAM 0.05%",
    "en_ingredients": "FLUOCINONIDE",
    "fr_ingredients": "Fluocinonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124829,
    "drug": {
      "current_status": "MARKETED",
      "id": 8166,
      "drug_code": 5439,
      "updated_date": "2025-05-15T02:30:33-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250755,
          "ingredient": {
            "id": 478,
            "ingredient_code": 7579,
            "en_name": "FLUOCINONIDE",
            "fr_name": "Fluocinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00598933",
      "brand_name": "TIAMOL CREAM 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60682",
      "number_of_ais": "1",
      "ai_group_no": "0106313001"
    },
    "created_date": "2020-09-22T21:20:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00598933",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2020-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-09-22T21:21:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TIAMOL CREAM 0.05%",
    "en_drug_common_name": "TIAMOL CREAM 0.05%",
    "fr_drug_brand_name": "TIAMOL CREAM 0.05%",
    "fr_drug_common_name": "TIAMOL CREAM 0.05%",
    "en_ingredients": "FLUOCINONIDE",
    "fr_ingredients": "Fluocinonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "25",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124834,
    "drug": {
      "current_status": "MARKETED",
      "id": 31884,
      "drug_code": 94362,
      "updated_date": "2025-12-03T00:33:09-05:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8262059,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262058,
          "ingredient": {
            "id": 4090,
            "ingredient_code": 22629,
            "en_name": "EMPAGLIFLOZIN",
            "fr_name": "EMPAGLIFLOZINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456621",
      "brand_name": "SYNJARDY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0258370006"
    },
    "created_date": "2020-09-22T23:44:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456621",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2020-09-24T00:00:00-04:00",
    "estimated_end_date": "2020-11-09T00:00:00-05:00",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNJARDY",
    "en_drug_common_name": "Synjardy 12.5/1000mg 6x10",
    "fr_drug_brand_name": "Symjardy",
    "fr_drug_common_name": "Synjardy 12.5/1000mg 6x10",
    "en_ingredients": "EMPAGLIFLOZIN\r\nMETFORMIN HYDROCHLORIDE",
    "fr_ingredients": "EMPAGLIFLOZINE\r\nChlorhydrate de metformine",
    "drug_strength": "12.5MG\r\n1000MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister Pack 6x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124837,
    "drug": {
      "current_status": "MARKETED",
      "id": 26494,
      "drug_code": 88807,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8259553,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259552,
          "ingredient": {
            "id": 3734,
            "ingredient_code": 20882,
            "en_name": "LINAGLIPTIN",
            "fr_name": "Linagliptine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403250",
      "brand_name": "JENTADUETO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0254133001"
    },
    "created_date": "2020-09-22T23:47:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403250",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2020-10-09T00:00:00-04:00",
    "estimated_end_date": "2021-03-01T00:00:00-05:00",
    "actual_start_date": "2020-10-13T00:00:00-04:00",
    "actual_end_date": "2021-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-27T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JENTADUETO",
    "en_drug_common_name": "Jentadueto 2.5/500mg 6x10",
    "fr_drug_brand_name": "Jentadueto",
    "fr_drug_common_name": "Jentadueto 2.5/500mg 6x10",
    "en_ingredients": "LINAGLIPTIN\r\nMETFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Linagliptine\r\nChlorhydrate de metformine",
    "drug_strength": "2.5MG\r\n500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister Pack 6x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124840,
    "drug": {
      "current_status": "MARKETED",
      "id": 26496,
      "drug_code": 88808,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8259555,
          "ingredient": {
            "id": 3734,
            "ingredient_code": 20882,
            "en_name": "LINAGLIPTIN",
            "fr_name": "Linagliptine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259554,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403269",
      "brand_name": "JENTADUETO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0254133002"
    },
    "created_date": "2020-09-22T23:49:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403269",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BD",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2020-10-05T00:00:00-04:00",
    "estimated_end_date": "2021-03-12T00:00:00-05:00",
    "actual_start_date": "2020-10-05T00:00:00-04:00",
    "actual_end_date": "2021-03-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-12T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JENTADUETO",
    "en_drug_common_name": "Jentadueto 2.5/850mg 6x10",
    "fr_drug_brand_name": "JENTADUETO",
    "fr_drug_common_name": "Jentadueto 2.5/850mg 6x10",
    "en_ingredients": "LINAGLIPTIN\r\nMETFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Linagliptine\r\nChlorhydrate de metformine",
    "drug_strength": "2.5MG\r\n850MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister Pack 6x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124848,
    "drug": {
      "current_status": "MARKETED",
      "id": 8698,
      "drug_code": 60566,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253508,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02237246",
      "brand_name": "FLOVENT DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685003"
    },
    "created_date": "2020-09-23T13:59:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237246",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2020-10-14T00:00:00-04:00",
    "actual_start_date": "2020-09-18T00:00:00-04:00",
    "actual_end_date": "2020-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FLOVENT DISKUS",
    "en_drug_common_name": "fluticasone propionate powder for inhalation",
    "fr_drug_brand_name": "FLOVENT DISKUS",
    "fr_drug_common_name": "propionate de fluticasone en poudre pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "250MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124877,
    "drug": {
      "current_status": "MARKETED",
      "id": 57516,
      "drug_code": 10025,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 968,
        "created_date": "2017-03-09T13:23:33-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 7555,
        "mfr_code": "",
        "name": "EURO-PHARM INTERNATIONAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "9400  BOUL. LANGELIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H1P 3H8",
        "post_office_box": "",
        "contact_information": "Ali Khamessan"
      },
      "drug_ingredients": [
        {
          "id": 8251268,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251267,
          "ingredient": {
            "id": 52,
            "ingredient_code": 8520,
            "en_name": "POLYMYXIN B",
            "fr_name": "Polymyxine B (Sulfate de polymyxine b)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "00701785",
      "brand_name": "OPTIMYXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69668",
      "number_of_ais": "2",
      "ai_group_no": "0205849001"
    },
    "created_date": "2020-09-24T15:21:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00701785",
    "company_name": "EURO-PHARM INTERNATIONAL CANADA INC",
    "atc_number": "S03AA",
    "atc_description": "ANTIINFECTIVES",
    "anticipated_start_date": "2020-11-01T00:00:00-04:00",
    "estimated_end_date": "2026-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-11-03T16:18:43-05:00",
    "status": "active_confirmed",
    "en_comments": "Reason for shortage: Transfer of manufacturing site.\r\nThe estimated end date depends on approval timelines for the manufacturing site transfer.",
    "fr_comments": "Raison pour la rupture: Transfert du site de fabrication. La date de fin de rupture estimée dépend des délais d'approbation de ce transfert.",
    "en_drug_brand_name": "OPTIMYXIN",
    "en_drug_common_name": "Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution",
    "fr_drug_brand_name": "Optimyxin",
    "fr_drug_common_name": "Solution oto/ophtalmique de gramicidine et de sulfate de polymyxine B",
    "en_ingredients": "GRAMICIDIN\r\nPOLYMYXIN B",
    "fr_ingredients": "Gramicidine\r\nPolymyxine B",
    "drug_strength": "0.025MG\r\n10000UNIT",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOTIC\r\nOPHTHALMIC\r\nOTIC",
    "drug_route_fr": "Ophtalmique\r\nOtique\r\nOphtalmique\r\nOtique",
    "drug_package_quantity": "10 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124896,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19804,
      "drug_code": 81139,
      "updated_date": "2025-05-15T04:14:41-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8347024,
          "ingredient": {
            "id": 660,
            "ingredient_code": 10187,
            "en_name": "AMITRIPTYLINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amitriptyline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326043",
      "brand_name": "TEVA-AMITRIPTYLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101524001"
    },
    "created_date": "2020-09-24T17:47:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02326043",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2020-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-24T17:47:40-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-AMITRIPTYLINE",
    "en_drug_common_name": "AMITRIPTYLINE 10MG TABLETS",
    "fr_drug_brand_name": "TEVA-AMITRIPTYLINE 10MG TABLETS",
    "fr_drug_common_name": "AMITRIPTYLINE 10MG TABLETS",
    "en_ingredients": "AMITRIPTYLINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amitriptyline",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124899,
    "drug": {
      "current_status": "MARKETED",
      "id": 15466,
      "drug_code": 76056,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255534,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02275058",
      "brand_name": "TEVA-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294005"
    },
    "created_date": "2020-09-24T17:51:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02275058",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "discontinuation_date": "2020-09-23T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Item is discontinued/transitioned to ACT product",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-24T17:51:31-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR 150MG CAPS",
    "fr_drug_brand_name": "TEVA-VENLAFAXINE XR 150MG CAPS",
    "fr_drug_common_name": "VENLAFAXINE XR 150MG CAPS",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124918,
    "drug": {
      "current_status": "MARKETED",
      "id": 18908,
      "drug_code": 80162,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256603,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316099",
      "brand_name": "ACT QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2020-09-24T18:25:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316099",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-01-31T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-01T17:52:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE 100MG FC TABLETS",
    "fr_drug_brand_name": "ACT-QUETIAPINE 100MG FC TABLETS",
    "fr_drug_common_name": "QUETIAPINE 100MG FC TABLETS",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124953,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10620,
      "drug_code": 6620,
      "updated_date": "2025-12-03T01:02:00-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8280752,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00653217",
      "brand_name": "TEVA-ECTOSONE",
      "brand_name_fr": "",
      "descriptor": "SCALP LOTION",
      "pediatric_flag": false,
      "accession_number": "63693",
      "number_of_ais": "1",
      "ai_group_no": "0106299001"
    },
    "created_date": "2020-09-24T18:48:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00653217",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-01T17:53:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ECTOSONE",
    "en_drug_common_name": "ECTOSONE 0.1% SCALP LOTION",
    "fr_drug_brand_name": "TEVA-ECTOSONE 0.1% SCALP LOTION",
    "fr_drug_common_name": "ECTOSONE 0.1% SCALP LOTION",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "75ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124956,
    "drug": {
      "current_status": "MARKETED",
      "id": 15836,
      "drug_code": 76586,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255670,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280183",
      "brand_name": "TEVA-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555002"
    },
    "created_date": "2020-09-24T18:51:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02280183",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-26T21:14:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BETAHISTINE",
    "en_drug_common_name": "BETAHISTINE 8MG TAB",
    "fr_drug_brand_name": "TEVA-BETAHISTINE 8MG TAB",
    "fr_drug_common_name": "BETAHISTINE 8MG TAB",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124959,
    "drug": {
      "current_status": "MARKETED",
      "id": 12036,
      "drug_code": 69948,
      "updated_date": "2025-05-15T02:31:19-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254460,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245832",
      "brand_name": "NV-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830002"
    },
    "created_date": "2020-09-24T18:53:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245832",
    "company_name": "TEVA CANADA LIMITED",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T18:53:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NV-CLINDAMYCIN",
    "en_drug_common_name": "TV-CLINDAMYCIN 150MG CAPSULES (VET)",
    "fr_drug_brand_name": "TV-CLINDAMYCIN 150MG CAPSULES (VET)",
    "fr_drug_common_name": "TV-CLINDAMYCIN 150MG CAPSULES (VET)",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124962,
    "drug": {
      "current_status": "MARKETED",
      "id": 18512,
      "drug_code": 79783,
      "updated_date": "2025-05-15T02:32:11-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256476,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312336",
      "brand_name": "TEVA-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243003"
    },
    "created_date": "2020-09-24T18:55:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02312336",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-22T17:09:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM 10MG TAB",
    "fr_drug_brand_name": "TEVA-CITALOPRAM 10MG TAB",
    "fr_drug_common_name": "CITALOPRAM 10MG TAB",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAM",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124965,
    "drug": {
      "current_status": "MARKETED",
      "id": 16870,
      "drug_code": 77858,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255957,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293218",
      "brand_name": "TEVA-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2020-09-24T18:56:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293218",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2021-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-07T18:21:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM 20MG TABS",
    "fr_drug_brand_name": "TEVA-CITALOPRAM 20MG TABS",
    "fr_drug_common_name": "CITALOPRAM 20MG TABS",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAM",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124968,
    "drug": {
      "current_status": "MARKETED",
      "id": 16866,
      "drug_code": 77854,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255956,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293161",
      "brand_name": "TEVA-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2020-09-24T18:59:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293161",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-26T21:14:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL 75MG TAB",
    "fr_drug_brand_name": "TEVA-CLOPIDOGREL 75MG TAB",
    "fr_drug_common_name": "TEVA-CLOPIDOGREL 75MG TAB",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124971,
    "drug": {
      "current_status": "MARKETED",
      "id": 66089,
      "drug_code": 95114,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262462,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02463237",
      "brand_name": "TEVA-EVEROLIMUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682001"
    },
    "created_date": "2020-09-24T19:04:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02463237",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01XE",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T18:53:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EVEROLIMUS",
    "en_drug_common_name": "EVEROLIMUS 5MG TAB",
    "fr_drug_brand_name": "TEVA-EVEROLIMUS 5MG TAB",
    "fr_drug_common_name": "EVEROLIMUS 5MG TAB",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124974,
    "drug": {
      "current_status": "MARKETED",
      "id": 26116,
      "drug_code": 88465,
      "updated_date": "2025-05-15T02:33:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259424,
          "ingredient": {
            "id": 3134,
            "ingredient_code": 12429,
            "en_name": "IMATINIB",
            "fr_name": "Imatinib (Mésylate d'imatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399806",
      "brand_name": "TEVA-IMATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145503002"
    },
    "created_date": "2020-09-24T19:06:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02399806",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01XE",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-01T17:54:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-IMATINIB",
    "en_drug_common_name": "TEVA-IMATINIB MESYLATE 100MG TAB",
    "fr_drug_brand_name": "TEVA-IMATINIB MESYLATE 100MG TAB",
    "fr_drug_common_name": "IMATINIB MESYLATE 100MG TAB",
    "en_ingredients": "IMATINIB",
    "fr_ingredients": "IMATINIB MESYLATE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124977,
    "drug": {
      "current_status": "MARKETED",
      "id": 7592,
      "drug_code": 50343,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253353,
          "ingredient": {
            "id": 2246,
            "ingredient_code": 1855,
            "en_name": "KETOCONAZOLE",
            "fr_name": "Kétoconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231061",
      "brand_name": "TEVA-KETOCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116793001"
    },
    "created_date": "2020-09-24T19:08:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231061",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J02AB",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-KETOCONAZOLE",
    "en_drug_common_name": "KETOCONAZOLE 200MG TAB",
    "fr_drug_brand_name": "TEVA-KETOCONAZOLE 200MG TAB",
    "fr_drug_common_name": "KETOCONAZOLE 200MG TAB",
    "en_ingredients": "KETOCONAZOLE",
    "fr_ingredients": "Kétoconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124980,
    "drug": {
      "current_status": "MARKETED",
      "id": 7972,
      "drug_code": 5182,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250711,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00583421",
      "brand_name": "TEVA-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59857",
      "number_of_ais": "1",
      "ai_group_no": "0105911003"
    },
    "created_date": "2020-09-24T19:09:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00583421",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN",
    "en_drug_common_name": "CEPHALEXIN 500MG TAB",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN 500MG TAB",
    "fr_drug_common_name": "CEPHALEXIN 500MG TAB",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124983,
    "drug": {
      "current_status": "MARKETED",
      "id": 17654,
      "drug_code": 78712,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256204,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256203,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02301784",
      "brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE Z)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0222417002"
    },
    "created_date": "2020-09-24T19:10:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02301784",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-26T21:14:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LISINOPRIL/HCTZ (TYPE Z)",
    "en_drug_common_name": "LISINOPRIL/HCTZ Z 20/25MG TAB",
    "fr_drug_brand_name": "TEVA-LISINOPRIL/HCTZ Z 20/25MG TAB",
    "fr_drug_common_name": "LISINOPRIL/HCTZ Z 20/25MG TAB",
    "en_ingredients": "LISINOPRIL\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Lisinopril\r\nHydrochlorothiazide",
    "drug_strength": "20MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124986,
    "drug": {
      "current_status": "MARKETED",
      "id": 11066,
      "drug_code": 67216,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254157,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "375",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243313",
      "brand_name": "TEVA-NAPROXEN EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634004"
    },
    "created_date": "2020-09-24T19:18:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243313",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-22T17:10:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN EC",
    "en_drug_common_name": "NAPROXEN-EC 375MG TAB",
    "fr_drug_brand_name": "TEVA-NAPROXEN-EC 375MG TAB",
    "fr_drug_common_name": "NAPROXEN-EC 375MG TAB",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "375MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124989,
    "drug": {
      "current_status": "MARKETED",
      "id": 13000,
      "drug_code": 72255,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254749,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247945",
      "brand_name": "TEVA-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2020-09-24T19:42:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247945",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T18:54:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL 2.5MG CAPS",
    "fr_drug_brand_name": "TEVA-RAMIPRIL 2.5MG CAPS",
    "fr_drug_common_name": "RAMIPRIL 2.5MG CAPS",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124992,
    "drug": {
      "current_status": "MARKETED",
      "id": 25788,
      "drug_code": 88171,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259304,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396688",
      "brand_name": "TEVA-RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2020-09-24T19:45:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396688",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-30T13:57:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN OD 10MG TAB",
    "fr_drug_brand_name": "TEVA-RIZATRIPTAN OD 10MG TAB",
    "fr_drug_common_name": "RIZATRIPTAN OD 10MG TAB",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 6's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124995,
    "drug": {
      "current_status": "MARKETED",
      "id": 2124,
      "drug_code": 14504,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251972,
          "ingredient": {
            "id": 1080,
            "ingredient_code": 2023,
            "en_name": "SUCRALFATE",
            "fr_name": "Sucralfate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02045702",
      "brand_name": "TEVA-SUCRALFATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76137",
      "number_of_ais": "1",
      "ai_group_no": "0114237002"
    },
    "created_date": "2020-09-24T19:47:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02045702",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BX",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-15T17:26:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SUCRALFATE",
    "en_drug_common_name": "SUCRALFATE 1GM TAB",
    "fr_drug_brand_name": "TEVA-SUCRALFATE 1GM TAB",
    "fr_drug_common_name": "SUCRALFATE 1GM TAB",
    "en_ingredients": "SUCRALFATE",
    "fr_ingredients": "Sucralfate",
    "drug_strength": "1G",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 124998,
    "drug": {
      "current_status": "MARKETED",
      "id": 30324,
      "drug_code": 9238,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251133,
          "ingredient": {
            "id": 3744,
            "ingredient_code": 2126,
            "en_name": "SULINDAC",
            "fr_name": "Sulindac"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00745588",
      "brand_name": "TEVA-SULINDAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68165",
      "number_of_ais": "1",
      "ai_group_no": "0112709001"
    },
    "created_date": "2020-09-24T19:48:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00745588",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SULINDAC",
    "en_drug_common_name": "SULINDAC 150MG TAB",
    "fr_drug_brand_name": "TEVA-SULINDAC 150MG TAB",
    "fr_drug_common_name": "SULINDAC 150MG TAB",
    "en_ingredients": "SULINDAC",
    "fr_ingredients": "Sulindac",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125001,
    "drug": {
      "current_status": "MARKETED",
      "id": 17208,
      "drug_code": 78267,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256073,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02297302",
      "brand_name": "ACT PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169001"
    },
    "created_date": "2020-09-24T19:49:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297302",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-19T14:23:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE 0.25MG TAB",
    "fr_drug_brand_name": "ACT-PRAMIPEXOLE 0.25MG TAB",
    "fr_drug_common_name": "PRAMIPEXOLE 0.25MG TAB",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125004,
    "drug": {
      "current_status": "MARKETED",
      "id": 18968,
      "drug_code": 80236,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256634,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316862",
      "brand_name": "TEVA-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618004"
    },
    "created_date": "2020-09-24T19:50:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316862",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-12T18:36:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE 2MG FC TAB",
    "fr_drug_brand_name": "ACT-ROPINIROLE 2MG FC TAB",
    "fr_drug_common_name": "ROPINIROLE 2MG FC TAB",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125007,
    "drug": {
      "current_status": "MARKETED",
      "id": 27444,
      "drug_code": 89677,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259929,
          "ingredient": {
            "id": 2634,
            "ingredient_code": 20821,
            "en_name": "TOLTERODINE TARTRATE",
            "fr_name": "Toltérodine Tartrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02412209",
      "brand_name": "TEVA-TOLTERODINE LA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135202003"
    },
    "created_date": "2020-09-24T19:51:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02412209",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-12T18:37:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TOLTERODINE LA",
    "en_drug_common_name": "TOLTERODINE 4MG ER CAP",
    "fr_drug_brand_name": "TEVA-TOLTERODINE 4MG ER CAP",
    "fr_drug_common_name": "TOLTERODINE 4MG ER CAP",
    "en_ingredients": "TOLTERODINE TARTRATE",
    "fr_ingredients": "Toltérodine Tartrate",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125010,
    "drug": {
      "current_status": "MARKETED",
      "id": 18738,
      "drug_code": 80012,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256551,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314592",
      "brand_name": "TEVA-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434005"
    },
    "created_date": "2020-09-24T19:53:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314592",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2021-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-25T15:29:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE 60MG CAP",
    "fr_drug_brand_name": "ATOMOXETINE 60MG CAP",
    "fr_drug_common_name": "TEVA-ATOMOXETINE 60MG CAP",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125013,
    "drug": {
      "current_status": "MARKETED",
      "id": 17048,
      "drug_code": 78071,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256014,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295407",
      "brand_name": "TEVA-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643003"
    },
    "created_date": "2020-09-24T19:55:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295407",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-17T19:22:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE 10MG TAB",
    "fr_drug_brand_name": "TEVA-OMEPRAZOLE 10MG TAB",
    "fr_drug_common_name": "OMEPRAZOLE 10MG TAB",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125016,
    "drug": {
      "current_status": "MARKETED",
      "id": 18674,
      "drug_code": 79948,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256535,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313960",
      "brand_name": "TEVA-ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2020-09-24T19:56:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313960",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-22T17:10:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ZOLMITRIPTAN",
    "en_drug_common_name": "ZOLMITRIPTAN 2.5MG TABS",
    "fr_drug_brand_name": "TEVA-ZOLMITRIPTAN 2.5MG TABS",
    "fr_drug_common_name": "ZOLMITRIPTAN 2.5MG TABS",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125019,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27050,
      "drug_code": 89291,
      "updated_date": "2025-05-15T04:21:19-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8353251,
          "ingredient": {
            "id": 3864,
            "ingredient_code": 22109,
            "en_name": "ULIPRISTAL ACETATE",
            "fr_name": "Ulipristal Acétate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408163",
      "brand_name": "FIBRISTAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154390001"
    },
    "created_date": "2020-09-24T21:12:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408163",
    "company_name": "ALLERGAN INC",
    "atc_number": "G03XB",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "actual_start_date": "2020-09-24T00:00:00-04:00",
    "actual_end_date": "2020-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-10-23T17:50:51-04:00",
    "status": "resolved",
    "en_comments": "Product recall",
    "fr_comments": "Rappel de produit",
    "en_drug_brand_name": "FIBRISTAL",
    "en_drug_common_name": "ulipristal acetate",
    "fr_drug_brand_name": "Fibristal",
    "fr_drug_common_name": "Ulipristal Acétate",
    "en_ingredients": "ULIPRISTAL ACETATE",
    "fr_ingredients": "Ulipristal Acétate",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125028,
    "drug": {
      "current_status": "MARKETED",
      "id": 25630,
      "drug_code": 88042,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259257,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395312",
      "brand_name": "TEVA-TEMOZOLOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781004"
    },
    "created_date": "2020-09-25T13:32:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395312",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE 250MG CAPS",
    "fr_drug_brand_name": "ACT-TEMOZOLOMIDE 250MG CAPS",
    "fr_drug_common_name": "TEMOZOLOMIDE 250MG CAPS",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125031,
    "drug": {
      "current_status": "MARKETED",
      "id": 30228,
      "drug_code": 92278,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261042,
          "ingredient": {
            "id": 3194,
            "ingredient_code": 13053,
            "en_name": "BORTEZOMIB",
            "fr_name": "Bortézomib (Bortézomib, ester boronique de mannitol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02438399",
      "brand_name": "ACT BORTEZOMIB",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150433001"
    },
    "created_date": "2020-09-25T13:33:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438399",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "L01XX",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-09-23T00:00:00-04:00",
    "actual_end_date": "2020-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-22T17:44:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT BORTEZOMIB",
    "en_drug_common_name": "BORTEZOMIB 3.5MG PINJ",
    "fr_drug_brand_name": "ACT-BORTEZOMIB 3.5MG PINJ",
    "fr_drug_common_name": "BORTEZOMIB 3.5MG PINJ",
    "en_ingredients": "BORTEZOMIB",
    "fr_ingredients": "BORTEZOMIB",
    "drug_strength": "3.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intraveineuse\r\nSous-cutanée\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125049,
    "drug": {
      "current_status": "MARKETED",
      "id": 26394,
      "drug_code": 88737,
      "updated_date": "2025-05-15T02:33:50-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259533,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402548",
      "brand_name": "MAR-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261003"
    },
    "created_date": "2020-09-25T14:34:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402548",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2020-10-07T00:00:00-04:00",
    "estimated_end_date": "2020-11-20T00:00:00-05:00",
    "actual_start_date": "2020-10-07T00:00:00-04:00",
    "actual_end_date": "2020-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-25T14:10:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "MAR-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125052,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2020-09-25T14:37:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2020-10-08T00:00:00-04:00",
    "actual_start_date": "2020-09-24T00:00:00-04:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T19:05:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "6MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "2x0.5mL (Refill pack/L’emballage de recharge)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125057,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2020-09-25T14:46:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2020-10-14T00:00:00-04:00",
    "actual_start_date": "2020-09-24T00:00:00-04:00",
    "actual_end_date": "2020-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T19:06:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "6MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "2x0.5mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125066,
    "drug": {
      "current_status": "MARKETED",
      "id": 13182,
      "drug_code": 72636,
      "updated_date": "2025-05-15T02:31:29-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8254790,
          "ingredient": {
            "id": 3086,
            "ingredient_code": 12024,
            "en_name": "ZOLEDRONIC ACID",
            "fr_name": "Acide zolédronique (Acide zolédronique monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02248296",
      "brand_name": "ZOMETA CONCENTRATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141761002"
    },
    "created_date": "2020-09-25T15:38:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248296",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "anticipated_start_date": "2020-10-19T00:00:00-04:00",
    "actual_end_date": "2020-10-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T20:07:25-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ZOMETA CONCENTRATE",
    "en_drug_common_name": "ZOMETA CONCENTRATE VIAL 4MG/5ML",
    "fr_drug_brand_name": "ZOMETA CONCENTRATE",
    "fr_drug_common_name": "ZOMETA CONCENTRATE 4MG/5ML",
    "en_ingredients": "ZOLEDRONIC ACID",
    "fr_ingredients": "ZOLEDRONIC ACID",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125072,
    "drug": {
      "current_status": "MARKETED",
      "id": 11414,
      "drug_code": 67945,
      "updated_date": "2025-12-03T00:30:48-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254256,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02244002",
      "brand_name": "ESTRADOT 100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457037"
    },
    "created_date": "2020-09-25T15:44:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244002",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "anticipated_start_date": "2020-10-08T00:00:00-04:00",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-10-08T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T21:03:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTRADOT 100",
    "en_drug_common_name": "ESTRADOT 100UG 8'S",
    "fr_drug_brand_name": "ESTRADOT 100",
    "fr_drug_common_name": "ESTRADOT 100UG 8'S",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125076,
    "drug": {
      "current_status": "MARKETED",
      "id": 9030,
      "drug_code": 61606,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253559,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238213",
      "brand_name": "PROPECIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110002"
    },
    "created_date": "2020-09-25T16:19:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238213",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D11AX",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "anticipated_start_date": "2020-09-30T00:00:00-04:00",
    "estimated_end_date": "2020-10-13T00:00:00-04:00",
    "actual_start_date": "2020-09-28T00:00:00-04:00",
    "actual_end_date": "2020-10-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-07T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PROPECIA",
    "en_drug_common_name": "Finasteride tablets",
    "fr_drug_brand_name": "PROPECIA",
    "fr_drug_common_name": "Comprimés de finastéride",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125088,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23666,
      "drug_code": 86284,
      "updated_date": "2025-12-03T01:29:36-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8351018,
          "ingredient": {
            "id": 3762,
            "ingredient_code": 21077,
            "en_name": "PLERIXAFOR",
            "fr_name": "Plérixafor"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02377225",
      "brand_name": "MOZOBIL",
      "brand_name_fr": "",
      "descriptor": "24MG/1.2ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153050001"
    },
    "created_date": "2020-09-25T18:25:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02377225",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "L03AX",
    "atc_description": "IMMUNOSTIMULANTS",
    "anticipated_start_date": "2020-12-04T00:00:00-05:00",
    "actual_end_date": "2020-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-11-25T20:28:07-05:00",
    "status": "avoided_shortage",
    "en_comments": "production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability.",
    "fr_comments": "Délai de production et d'approvisionnement - Compte tenu des circonstances exceptionnelles, l’inventaire restant sera distribué sur allocation avec une limite de 2 flacons par commande. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "MOZOBIL",
    "en_drug_common_name": "Mozobil",
    "fr_drug_brand_name": "MOZOBIL",
    "fr_drug_common_name": "Mozobil",
    "en_ingredients": "PLERIXAFOR",
    "fr_ingredients": "Plérixafor",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1 x 2.0ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125104,
    "drug": {
      "current_status": "MARKETED",
      "id": 99948,
      "drug_code": 98049,
      "updated_date": "2020-04-03T06:54:14-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264262,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02490447",
      "brand_name": "PDP-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843005"
    },
    "created_date": "2020-09-25T20:27:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02490447",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-10-09T00:00:00-04:00",
    "actual_start_date": "2020-09-09T00:00:00-04:00",
    "actual_end_date": "2020-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "PDP-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "300mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125144,
    "drug": {
      "current_status": "MARKETED",
      "id": 100232,
      "drug_code": 98582,
      "updated_date": "2020-04-03T06:54:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264796,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8264795,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02495929",
      "brand_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720013"
    },
    "created_date": "2020-09-28T12:33:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02495929",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2020-10-19T00:00:00-04:00",
    "actual_start_date": "2020-10-19T00:00:00-04:00",
    "actual_end_date": "2020-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-20T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "INVENTORY AVAILABLE AT WHOLESALER",
    "fr_comments": "INVENTAIRE DISPONIBLE CHEZ GROSSISTE",
    "en_drug_brand_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
    "en_drug_common_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
    "fr_drug_brand_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
    "fr_drug_common_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "200MG\r\n1000MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10PSOIJ CA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125147,
    "drug": {
      "current_status": "MARKETED",
      "id": 100233,
      "drug_code": 98583,
      "updated_date": "2020-04-03T06:54:32-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264798,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8264797,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02495937",
      "brand_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720014"
    },
    "created_date": "2020-09-28T12:35:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02495937",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2020-10-19T00:00:00-04:00",
    "actual_start_date": "2020-10-19T00:00:00-04:00",
    "actual_end_date": "2020-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-20T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "INVENTORY AVAILABLE AT WHOLESALER",
    "fr_comments": "INVENTAIRE DISPONIBLE CHEZ GROSSISTE",
    "en_drug_brand_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
    "en_drug_common_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
    "fr_drug_brand_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
    "fr_drug_common_name": "AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "200MG\r\n2000MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 PSOIJ CA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125150,
    "drug": {
      "current_status": "MARKETED",
      "id": 59163,
      "drug_code": 94844,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262298,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460920",
      "brand_name": "SANDOZ ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162001"
    },
    "created_date": "2020-09-28T12:37:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460920",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-12-25T00:00:00-05:00",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2021-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-13T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ESOMEPRAZOLE",
    "en_drug_common_name": "SANDOZ ESOMEPRAZOLE",
    "fr_drug_brand_name": "SANDOZ ESOMEPRAZOLE",
    "fr_drug_common_name": "SANDOZ ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100GRT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125153,
    "drug": {
      "current_status": "MARKETED",
      "id": 6796,
      "drug_code": 4431,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8250633,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00527033",
      "brand_name": "FUROSEMIDE INJ USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57596",
      "number_of_ais": "1",
      "ai_group_no": "0101944003"
    },
    "created_date": "2020-09-28T12:38:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00527033",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2021-01-15T00:00:00-05:00",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2021-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-19T14:09:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FUROSEMIDE INJ USP",
    "en_drug_common_name": "FUROSEMIDE INJ USP",
    "fr_drug_brand_name": "FUROSEMIDE INJ USP",
    "fr_drug_common_name": "FUROSEMIDE INJ USP",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "10MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "4ML 10 LIVI CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125156,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 940,
      "drug_code": 12218,
      "updated_date": "2025-12-03T01:05:38-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8289477,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "25",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00401633",
      "brand_name": "FUROSEMIDE SPECIAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73266",
      "number_of_ais": "1",
      "ai_group_no": "0101944003"
    },
    "created_date": "2020-09-28T12:40:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00401633",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "hc_updated_date": "2024-05-13T12:44:11-04:00",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2024-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-13T12:44:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FUROSEMIDE SPECIAL",
    "en_drug_common_name": "FUROSEMIDE SPECIAL",
    "fr_drug_brand_name": "FUROSEMIDE SPECIAL",
    "fr_drug_common_name": "FUROSEMIDE SPECIAL",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "250MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25 ML 10LIVI CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125159,
    "drug": {
      "current_status": "MARKETED",
      "id": 23510,
      "drug_code": 86095,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258478,
          "ingredient": {
            "id": 3178,
            "ingredient_code": 13366,
            "en_name": "MEMANTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mémantine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375532",
      "brand_name": "SANDOZ MEMANTINE FCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150423001"
    },
    "created_date": "2020-09-28T12:42:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375532",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06DX",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2021-01-29T00:00:00-05:00",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2021-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2021-02-02T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MEMANTINE FCT",
    "en_drug_common_name": "SANDOZ MEMANTINE FCT",
    "fr_drug_brand_name": "SANDOZ MEMANTINE FCT",
    "fr_drug_common_name": "SANDOZ MEMANTINE FCT",
    "en_ingredients": "MEMANTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mémantine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 FCT BO V1 CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125162,
    "drug": {
      "current_status": "MARKETED",
      "id": 26282,
      "drug_code": 88649,
      "updated_date": "2025-05-15T02:33:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259457,
          "ingredient": {
            "id": 3086,
            "ingredient_code": 12024,
            "en_name": "ZOLEDRONIC ACID",
            "fr_name": "Acide zolédronique (Acide zolédronique monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02401606",
      "brand_name": "ZOLEDRONIC ACID - Z",
      "brand_name_fr": "ACIDE ZOLÉDRONIQUE - Z",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141761002"
    },
    "created_date": "2020-09-28T12:44:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02401606",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2020-10-16T00:00:00-04:00",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-10-13T12:22:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOLEDRONIC ACID - Z",
    "en_drug_common_name": "ZOLEDRONIC ACID - Z",
    "fr_drug_brand_name": "ZOLEDRONIC ACID - Z",
    "fr_drug_common_name": "ZOLEDRONIC ACID - Z",
    "en_ingredients": "ZOLEDRONIC ACID",
    "fr_ingredients": "ZOLEDRONIC ACID - Z",
    "drug_strength": "4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ML 1LIVI CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125179,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2292,
      "drug_code": 15173,
      "updated_date": "2025-05-15T03:41:12-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8294650,
          "ingredient": {
            "id": 1120,
            "ingredient_code": 10196,
            "en_name": "NITROFURANTOIN",
            "fr_name": "Nitrofurantoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02063662",
      "brand_name": "MACROBID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76854",
      "number_of_ais": "1",
      "ai_group_no": "0101480001"
    },
    "created_date": "2020-09-28T19:04:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02063662",
    "company_name": "ALLERGAN INC",
    "atc_number": "J01XE",
    "atc_description": "OTHER ANTIBACTERIALS",
    "anticipated_start_date": "2020-10-02T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MACROBID",
    "en_drug_common_name": "nitrofurantoin",
    "fr_drug_brand_name": "Macrobid",
    "fr_drug_common_name": "Nitrofurantoïne",
    "en_ingredients": "NITROFURANTOIN",
    "fr_ingredients": "Nitrofurantoïne",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125182,
    "drug": {
      "current_status": "MARKETED",
      "id": 5174,
      "drug_code": 3186,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250495,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00451207",
      "brand_name": "TIMOPTIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "53447",
      "number_of_ais": "1",
      "ai_group_no": "0131275002"
    },
    "created_date": "2020-09-28T19:10:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00451207",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-27T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TIMOPTIC",
    "en_drug_common_name": "TIMOPTIC",
    "fr_drug_brand_name": "TIMOPTIC",
    "fr_drug_common_name": "TIMOPTIC",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "TIMOLOL",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125196,
    "drug": {
      "id": 66490,
      "drug_code": 98004,
      "updated_date": "2025-12-03T00:34:29-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8264221,
          "ingredient": {
            "id": 3156,
            "ingredient_code": 13346,
            "en_name": "ELETRIPTAN",
            "fr_name": "Élétriptan (Bromhydrate d'élétriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02489961",
      "brand_name": "PRO-ELETRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150241001"
    },
    "created_date": "2020-09-28T19:25:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02489961",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2021-01-29T00:00:00-05:00",
    "actual_start_date": "2020-09-28T00:00:00-04:00",
    "actual_end_date": "2021-01-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-01-21T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ELETRIPTAN",
    "en_drug_common_name": "ELETRIPTAN",
    "fr_drug_brand_name": "ELETRIPTAN",
    "fr_drug_common_name": "ELETRIPTAN",
    "en_ingredients": "ELETRIPTAN",
    "fr_ingredients": "ELETRIPTAN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125203,
    "drug": {
      "current_status": "MARKETED",
      "id": 57689,
      "drug_code": 94736,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262254,
          "ingredient": {
            "id": 3528,
            "ingredient_code": 20435,
            "en_name": "ARIPIPRAZOLE",
            "fr_name": "Aripiprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460076",
      "brand_name": "AURO-ARIPIPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152514004"
    },
    "created_date": "2020-09-28T21:04:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460076",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-11-13T00:00:00-05:00",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-11-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-11-24T16:58:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-ARIPIPRAZOLE",
    "en_drug_common_name": "Aripiprazole",
    "fr_drug_brand_name": "AURO-ARIPIPRAZOLE",
    "fr_drug_common_name": "Aripiprazole",
    "en_ingredients": "ARIPIPRAZOLE",
    "fr_ingredients": "Aripiprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125225,
    "drug": {
      "current_status": "MARKETED",
      "id": 31284,
      "drug_code": 93497,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261599,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449153",
      "brand_name": "AURO-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555003"
    },
    "created_date": "2020-09-29T13:48:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449153",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-29T14:54:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-BETAHISTINE",
    "en_drug_common_name": "Betahistine Hydrochloride",
    "fr_drug_brand_name": "AURO-BETAHISTINE",
    "fr_drug_common_name": "Chlorhydrate de bêta-histine",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125228,
    "drug": {
      "current_status": "MARKETED",
      "id": 30078,
      "drug_code": 92123,
      "updated_date": "2025-05-15T02:34:39-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260952,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436914",
      "brand_name": "AURO-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830003"
    },
    "created_date": "2020-09-29T13:50:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436914",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-10-26T16:04:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CLINDAMYCIN",
    "en_drug_common_name": "Clindamycin",
    "fr_drug_brand_name": "AURO-CLINDAMYCIN",
    "fr_drug_common_name": "Clindamycin",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "Clindamycin",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125235,
    "drug": {
      "current_status": "MARKETED",
      "id": 61224,
      "drug_code": 96271,
      "updated_date": "2025-05-15T02:36:22-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8263095,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8263094,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02473305",
      "brand_name": "AURO-QUINAPRIL HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0231789002"
    },
    "created_date": "2020-09-29T14:02:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02473305",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-10-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-QUINAPRIL HCTZ",
    "en_drug_common_name": "Quinapril Hydrochlorothiazide",
    "fr_drug_brand_name": "AURO-QUINAPRIL HCTZ",
    "fr_drug_common_name": "Quinapril Hydrochlorothiazide",
    "en_ingredients": "QUINAPRIL\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Quinapril Hydrochlorothiazide",
    "drug_strength": "20MG\r\n12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x14 & 90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125238,
    "drug": {
      "current_status": "MARKETED",
      "id": 61226,
      "drug_code": 96273,
      "updated_date": "2025-05-15T02:36:22-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8263097,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8263096,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02473321",
      "brand_name": "AURO-QUINAPRIL HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0231789003"
    },
    "created_date": "2020-09-29T14:04:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02473321",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2021-01-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-01-08T22:18:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-QUINAPRIL HCTZ",
    "en_drug_common_name": "Quinapril Hydrochlorothiazide",
    "fr_drug_brand_name": "AURO-QUINAPRIL HCTZ",
    "fr_drug_common_name": "Quinapril Hydrochlorothiazide",
    "en_ingredients": "QUINAPRIL\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Quinapril Hydrochlorothiazide",
    "drug_strength": "20MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x14",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125245,
    "drug": {
      "current_status": "MARKETED",
      "id": 24726,
      "drug_code": 87299,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8258922,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387409",
      "brand_name": "AURO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858003"
    },
    "created_date": "2020-09-29T14:12:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387409",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-12-31T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-RAMIPRIL",
    "en_drug_common_name": "Ramipril",
    "fr_drug_brand_name": "AURO-RAMIPRIL",
    "fr_drug_common_name": "Ramipril",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 & 500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125264,
    "drug": {
      "current_status": "MARKETED",
      "id": 31864,
      "drug_code": 94326,
      "updated_date": "2025-12-03T00:33:09-05:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262036,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262035,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456397",
      "brand_name": "AURO-TELMISARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783002"
    },
    "created_date": "2020-09-29T14:48:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456397",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2025-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-05-16T15:53:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-TELMISARTAN HCTZ",
    "en_drug_common_name": "Telmisartan Hydrochlorothiazide",
    "fr_drug_brand_name": "AURO-TELMISARTAN HCTZ",
    "fr_drug_common_name": "Telmisartan Hydrochlorothiazide",
    "en_ingredients": "TELMISARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Telmisartan\r\nHydrochlorothiazide",
    "drug_strength": "80MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125276,
    "drug": {
      "current_status": "MARKETED",
      "id": 20836,
      "drug_code": 8274,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251076,
          "ingredient": {
            "id": 3628,
            "ingredient_code": 6212,
            "en_name": "SODIUM TETRADECYL SULFATE",
            "fr_name": "Tétradécyl sulfate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00511226",
      "brand_name": "TROMBOJECT 3%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66605",
      "number_of_ais": "1",
      "ai_group_no": "0107541002"
    },
    "created_date": "2020-09-29T15:26:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00511226",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "C05BB",
    "atc_description": "ANTIVARICOSE THERAPY",
    "estimated_end_date": "2020-12-11T00:00:00-05:00",
    "actual_start_date": "2020-09-04T00:00:00-04:00",
    "actual_end_date": "2021-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-01-18T15:43:59-05:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay",
    "fr_comments": "Délai de fabrication",
    "en_drug_brand_name": "TROMBOJECT 3% INJ 30MG/ML",
    "en_drug_common_name": "Sodium Tetradecyl Sulfate Injection",
    "fr_drug_brand_name": "Tromboject",
    "fr_drug_common_name": "Injection de tétradécyl sulfate de sodium",
    "en_ingredients": "SODIUM TETRADECYL SULFATE",
    "fr_ingredients": "Tétradécyl sulfate de sodium",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 2mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125279,
    "drug": {
      "current_status": "MARKETED",
      "id": 20836,
      "drug_code": 8274,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251076,
          "ingredient": {
            "id": 3628,
            "ingredient_code": 6212,
            "en_name": "SODIUM TETRADECYL SULFATE",
            "fr_name": "Tétradécyl sulfate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00511226",
      "brand_name": "TROMBOJECT 3%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66605",
      "number_of_ais": "1",
      "ai_group_no": "0107541002"
    },
    "created_date": "2020-09-29T15:30:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00511226",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "C05BB",
    "atc_description": "ANTIVARICOSE THERAPY",
    "anticipated_start_date": "2020-10-02T00:00:00-04:00",
    "estimated_end_date": "2020-12-08T00:00:00-05:00",
    "actual_start_date": "2020-09-30T00:00:00-04:00",
    "actual_end_date": "2021-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-01-18T15:43:43-05:00",
    "status": "resolved",
    "en_comments": "Manufacturing delay",
    "fr_comments": "Délai de fabrication",
    "en_drug_brand_name": "TROMBOJECT 3% INJ 30MG/ML",
    "en_drug_common_name": "Sodium Tetradecyl Sulfate Injection",
    "fr_drug_brand_name": "Tromboject",
    "fr_drug_common_name": "Injection de tétradécyl sulfate de sodium",
    "en_ingredients": "SODIUM TETRADECYL SULFATE",
    "fr_ingredients": "Tétradécyl sulfate de sodium",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5 x 5mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125282,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6130,
      "drug_code": 42841,
      "updated_date": "2025-05-15T03:49:37-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8312669,
          "ingredient": {
            "id": 22,
            "ingredient_code": 6311,
            "en_name": "FLUOROURACIL",
            "fr_name": "Fluorouracil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02182742",
      "brand_name": "FLUOROURACIL INJECTION USP",
      "brand_name_fr": "FLUOROURACILE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9007",
      "number_of_ais": "1",
      "ai_group_no": "0107505001"
    },
    "created_date": "2020-09-29T19:23:35-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02182742",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "discontinuation_date": "2020-11-30T00:00:00-05:00",
    "anticipated_discontinuation_date": "2020-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-01-17T21:25:15-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "FLUOROURACIL INJECTION USP",
    "en_drug_common_name": "Fluorouracil Injection USP",
    "fr_drug_brand_name": "Fluorouracile Injectable USP",
    "fr_drug_common_name": "Fluorouracile Injectable USP",
    "en_ingredients": "FLUOROURACIL",
    "fr_ingredients": "Fluorouracil",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100mL vial",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125302,
    "drug": {
      "current_status": "MARKETED",
      "id": 49642,
      "drug_code": 92813,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261324,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261323,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443449",
      "brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED-RELEASE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252870002"
    },
    "created_date": "2020-09-30T11:56:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443449",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2020-12-23T00:00:00-05:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-30T15:26:10-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "en_drug_common_name": "NAPROXEN/ESOMEPRAZOLE",
    "fr_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "fr_drug_common_name": "NAPROXEN/ESOMEPRAZOLE MR",
    "en_ingredients": "NAPROXEN\r\nESOMEPRAZOLE",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG\r\n20MG",
    "drug_dosage_form": "TABLET (IMMEDIATE AND DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate et retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125311,
    "drug": {
      "current_status": "MARKETED",
      "id": 3936,
      "drug_code": 19588,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252513,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172062",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 25MCG",
      "pediatric_flag": false,
      "accession_number": "81885",
      "number_of_ais": "1",
      "ai_group_no": "0107794018"
    },
    "created_date": "2020-09-30T12:01:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172062",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-10-09T00:00:00-04:00",
    "estimated_end_date": "2020-11-03T00:00:00-05:00",
    "actual_start_date": "2020-10-09T00:00:00-04:00",
    "actual_end_date": "2020-11-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-03T15:06:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE SODIUM",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE SODIUM",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "25MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125332,
    "drug": {
      "current_status": "MARKETED",
      "id": 9248,
      "drug_code": 62232,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253610,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02238796",
      "brand_name": "APO-BECLOMETHASONE NASAL SPRAY",
      "brand_name_fr": "",
      "descriptor": "METERED DOSE SPRAY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106320002"
    },
    "created_date": "2020-09-30T13:49:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238796",
    "company_name": "APOTEX INC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2020-10-09T00:00:00-04:00",
    "actual_start_date": "2020-09-28T00:00:00-04:00",
    "actual_end_date": "2020-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-13T12:45:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BECLOMETHASONE NASAL SPRAY",
    "en_drug_common_name": "BECLOMETHASONE",
    "fr_drug_brand_name": "APO-BECLO N/SPRY",
    "fr_drug_common_name": "BECLOMETHASONE",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "200 doses",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125335,
    "drug": {
      "current_status": "MARKETED",
      "id": 2866,
      "drug_code": 16947,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252177,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02126222",
      "brand_name": "AA-IPRAVENT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79061",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2020-09-30T13:57:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02126222",
    "company_name": "APOTEX INC",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "actual_start_date": "2020-09-28T00:00:00-04:00",
    "actual_end_date": "2020-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-13T12:50:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-IPRAVENT SOLUTION - INH 250MCG/ML",
    "en_drug_common_name": "IPRAVENT",
    "fr_drug_brand_name": "APO-IPRAVENT SOLUTION",
    "fr_drug_common_name": "IPRAVENT",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125338,
    "drug": {
      "current_status": "MARKETED",
      "id": 51711,
      "drug_code": 93838,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261771,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02451980",
      "brand_name": "APO-TENOFOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152569001"
    },
    "created_date": "2020-09-30T14:03:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02451980",
    "company_name": "APOTEX INC",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-11-27T00:00:00-05:00",
    "actual_start_date": "2020-09-28T00:00:00-04:00",
    "actual_end_date": "2020-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-16T13:59:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TENOFOVIR",
    "en_drug_common_name": "TENOFOVIR",
    "fr_drug_brand_name": "APO-TENOFOVIR",
    "fr_drug_common_name": "TENOFOVIR",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125354,
    "drug": {
      "current_status": "MARKETED",
      "id": 3024,
      "drug_code": 1750,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250314,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250313,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00038903",
      "brand_name": "5% DEXTROSE AND 0.45% SODIUM CHLORIDE",
      "brand_name_fr": "5% DEXTROSE ET 0,45% DE CHLORURE DE SODIUM",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "43684",
      "number_of_ais": "2",
      "ai_group_no": "0200203002"
    },
    "created_date": "2020-09-30T16:03:29-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00038903",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "discontinuation_date": "2020-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-30T16:05:22-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "5% DEXTROSE AND 0.45% SODIUM CHLORIDE",
    "en_drug_common_name": "Dextrose and Sodium Chloride Injection USP",
    "fr_drug_brand_name": "5% Dextrose et 0,45% de chlorure de sodium",
    "fr_drug_common_name": "Dextrose et chlorure de sodium injectables USP",
    "en_ingredients": "DEXTROSE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Dextrose\r\nChlorure de sodium",
    "drug_strength": "50MG\r\n4.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125361,
    "drug": {
      "current_status": "MARKETED",
      "id": 60186,
      "drug_code": 89992,
      "updated_date": "2025-05-15T02:34:05-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260074,
          "ingredient": {
            "id": 3280,
            "ingredient_code": 12477,
            "en_name": "TRAVOPROST",
            "fr_name": "Travoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.004",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        },
        {
          "id": 8260073,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02415305",
      "brand_name": "APO-TRAVOPROST-TIMOP PQ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251602001"
    },
    "created_date": "2020-09-30T17:31:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415305",
    "company_name": "APOTEX INC",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-04-01T00:00:00-04:00",
    "actual_start_date": "2022-03-15T00:00:00-04:00",
    "actual_end_date": "2022-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-04-01T18:13:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRAVOPROST-TIMOP PQ",
    "en_drug_common_name": "TRAVOPROST",
    "fr_drug_brand_name": "APO-TRAVOPROST-TIMOP PQ",
    "fr_drug_common_name": "TRAVOPROST",
    "en_ingredients": "TRAVOPROST\r\nTIMOLOL",
    "fr_ingredients": "Travoprost",
    "drug_strength": "0.004%\r\n0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125363,
    "drug": {
      "current_status": "MARKETED",
      "id": 60186,
      "drug_code": 89992,
      "updated_date": "2025-05-15T02:34:05-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260074,
          "ingredient": {
            "id": 3280,
            "ingredient_code": 12477,
            "en_name": "TRAVOPROST",
            "fr_name": "Travoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.004",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        },
        {
          "id": 8260073,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02415305",
      "brand_name": "APO-TRAVOPROST-TIMOP PQ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251602001"
    },
    "created_date": "2020-09-30T17:31:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415305",
    "company_name": "APOTEX INC",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-09-28T00:00:00-04:00",
    "actual_end_date": "2020-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-02T17:05:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRAVOPROST-TIMOP PQ",
    "en_drug_common_name": "TRAVOPROST",
    "fr_drug_brand_name": "APO-TRAV-TIMOP",
    "fr_drug_common_name": "TRAVOPROST",
    "en_ingredients": "TRAVOPROST\r\nTIMOLOL",
    "fr_ingredients": "Travoprost",
    "drug_strength": "0.004%\r\n0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125366,
    "drug": {
      "current_status": "MARKETED",
      "id": 30154,
      "drug_code": 92202,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261013,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "55",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02437635",
      "brand_name": "APO-TRIAMCINOLONE AQ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106310010"
    },
    "created_date": "2020-09-30T17:34:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437635",
    "company_name": "APOTEX INC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "actual_start_date": "2020-09-28T00:00:00-04:00",
    "actual_end_date": "2020-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-13T12:52:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRIAMCINOLONE AQ",
    "en_drug_common_name": "TRIAMCINOLONE",
    "fr_drug_brand_name": "APO-TRIAMCINOLONE AQ",
    "fr_drug_common_name": "TRIAMCINOLONE AQ",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "55MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "120 MS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125369,
    "drug": {
      "current_status": "MARKETED",
      "id": 29876,
      "drug_code": 91923,
      "updated_date": "2025-05-15T02:34:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260835,
          "ingredient": {
            "id": 3728,
            "ingredient_code": 933,
            "en_name": "ZOLPIDEM TARTRATE",
            "fr_name": "Tartrate de zolpidem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434946",
      "brand_name": "APO-ZOLPIDEM ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122857002"
    },
    "created_date": "2020-09-30T17:44:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434946",
    "company_name": "APOTEX INC",
    "atc_number": "N05CF",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2020-11-20T00:00:00-05:00",
    "actual_start_date": "2020-09-28T00:00:00-04:00",
    "actual_end_date": "2020-11-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-19T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ZOLPIDEM ODT",
    "en_drug_common_name": "ZOLPIDEM",
    "fr_drug_brand_name": "APO-ZOLPIDEM ODT",
    "fr_drug_common_name": "ZOLPIDEM",
    "en_ingredients": "ZOLPIDEM TARTRATE",
    "fr_ingredients": "Tartrate de zolpidem",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 125376,
    "drug": {
      "current_status": "MARKETED",
      "id": 20834,
      "drug_code": 82719,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 1216,
        "created_date": "2017-03-09T13:23:57-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 12463,
        "mfr_code": "",
        "name": "GENMED A DIVISION OF PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-800-387-4974\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8257371,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257370,
          "ingredient": {
            "id": 930,
            "ingredient_code": 1859,
            "en_name": "MISOPROSTOL",
            "fr_name": "Misoprostol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02341697",
      "brand_name": "GD-DICLOFENAC/MISOPROSTOL 75",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0222885004"
    },
    "created_date": "2020-09-30T21:50:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341697",
    "company_name": "GENMED A DIVISION OF PFIZER CANADA ULC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-11-16T00:00:00-05:00",
    "actual_start_date": "2020-09-30T00:00:00-04:00",
    "actual_end_date": "2020-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-11-12T15:06:43-05:00",
    "status": "resolved",
    "en_comments": "Limited inventory available and on preventative allocation.",
    "fr_comments": "Un inventaire limité est disponible en allocation préventive.",
    "en_drug_brand_name": "GD-DICLOFENAC/MISOPROSTOL 75",
    "en_drug_common_name": "GD-DICLOFENAC/MISOPROSTOL",
    "fr_drug_brand_name": "GD-DICLOFENAC/MISOPROSTOL 75",
    "fr_drug_common_name": "GD-DICLOFENAC/MISOPROSTOL",
    "en_ingredients": "DICLOFENAC SODIUM\r\nMISOPROSTOL",
    "fr_ingredients": "Diclofénac sodique\r\nMisoprostol",
    "drug_strength": "75MG\r\n200MCG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]